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ABSTRACT 
 
Comparison of Methods for Assessing Viability of Equine Spermatozoa and 
Effects of Seminal Plasma on Viability and Motion Characteristics of Equine 
Spermatozoa. (December 2009) 
Mary Lauren Foster, B.S., Texas A&M University-Commerce 
Chair of Advisory Committee: Dr. Charles Love 
 
 Assessment of sperm viability is an important component for evaluating 
stallion sperm quality.  The flow cytometer is considered the standard in the 
assessment of sperm plasma membrane integrity (viability); however, this 
instrument is costly to purchase and use, and it requires an experienced 
technician to operate it.  The growing practice of assisted reproductive 
technologies (ARTs) in the equine industry has increased the need for an 
accurate but cost-effective means of determining sperm membrane viability.  
The NucleoCounter® SP-100TM is reported to be an accurate, easy-to-perform, 
and an efficient stallion-side test for sperm membrane viability.   
To evaluate usefulness of the NucleoCounter® SP-100TM  for assessing 
sperm membrane integrity, neat semen was subjected to four treatments with 
varying seminal plasma volumes and sperm concentrations.  Sperm membrane 
viability was assessed immediately, and at 24 and 48 hours after cooled-storage 
using three methods: 1) flow cytometer utilizing the fluorescent vital stains 
  
 
iv 
SYBR-14/propidium iodide; 2) NucleoCounter® SP-100TM utilizing the 
fluorescent vital stain propidium iodide; 3) eosin-nigrosin stained air-dried 
smears of semen.  Sperm motion characteristics (total and progressive motility) 
were assessed using a computer assisted sperm motion analyzer (CASMA) and 
results were compared to sperm membrane viability to determine the 
relationship between sperm membrane viability and motion characteristics.  
Results were compared statistically by: 1) analysis of variance (ANOVA); 2) 
linear regression analysis; 3) coefficient of variation on untransformed and 
transformed data (arc sine square root); and 3) the agreement of two 
instruments, by means of which the difference between measurements of the 
two instruments were plotted on the y-axis and the average of measurements 
from the two instruments were plotted on the x-axis.   
 Results obtained with the NucleoCounter® SP-100TM agreed best with the 
flow cytometer, and least with eosin-nigrosin staining.  Coefficients of variation 
were ≤ 5% for the three methods (transformed data).  Sperm motion 
characteristics and sperm viability were similar among treatments at Time 0.  At 
Times 24 and 48, sperm motion characteristics decreased at a more significant 
rate compared to viability in the treatments containing ≥ 50% seminal plasma, 
whereas differences among treatments were only significant at seminal plasma 
concentrations above 50% when only sperm membrane viability was 
considered. 
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1. INTRODUCTION 
The growing use of assisted reproductive technologies (ARTs) in the 
equine industry has increased the requirement for an accurate, repeatable, and 
cost-effective means of determining the quality of the sperm to be used in these 
procedures.  These technologies include artificial insemination, low-dose, deep-
horn insemination, and intracytoplasmic sperm injection (ICSI).  Fluorescent 
probes for measurement of sperm viability have been used to label sperm 
compartments in several species including boars, rams, rats, rabbits, humans, 
turkeys [1], stallions [2, 3], and dogs [4].  Specific fluorescent probes evaluated 
in this study include SYBR-14, propidium iodide (PI) and JC-1, which measure 
sperm membrane integrity (the term viability will be used hereafter for simplicity) 
by demonstrating membrane permeability or mitochondrial membrane potential.  
The semen sample is incubated with the fluorescent labels, and results are 
analyzed on a flow cytometer to allow objective assessment of thousands of 
sperm per sample.  Because of its objectivity, ability to differentiate slight 
variations in staining intensity, and ability to analyze high numbers of sperm, the 
flow cytometer is considered the “gold standard” for assessment of viability, and 
is commonly used to evaluate sperm membrane viability assays.  The combined 
trends in ARTs and the continued use of stallions with moderate to poor semen 
quality have made proper handling, processing and evaluation of semen more    
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critical for the equine breeding industry. 
Seminal plasma content and determination of sperm concentration are 
two important considerations when processing semen.  Optimal seminal plasma 
concentration and sperm concentrations in extended semen are generally 
accepted to be between 5-20% and 25 to 50 x 106 sperm/mL, respectively [5, 6].  
Although these ranges are considered optimal, the effects of seminal plasma 
levels can vary among stallions, ejaculates, and types of processing performed 
(i.e. cooled vs. frozen) [7-12]. 
 The relationship between sperm membrane viability and motion 
characteristics in cooled-stored equine sperm is not clear, and few studies have 
attempted to address this issue.  Brinsko et al. in 2003 found a strong correlation 
(R>0.80; P<0.001) between motility and membrane viability of equine sperm 
when assessed by computer-assisted sperm motion analysis and staining with 
carboxyfluoresein diacetate-propidium iodide, respectively [13].  Another study 
conducted in 2003 also found a strong correlation (R=0.98) between total 
motility of equine sperm as assessed by computer-assisted sperm motion 
analysis and membrane viability assessed by two staining techniques (SYBR-
14/PI and SYBR-14/PI/JC-1) using the flow cytometer [2].  Both studies utilized 
treatments with varying percentages of dead sperm added, and results were 
assessed after a 24-hour cooling period.  Results after addition of dead (frozen-
thawed) sperm, which may have superphysiological changes to the sperm 
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membrane may not be directly applicable to findings on sperm death as it occurs 
after storage or in response to more physiological insults. 
 Many studies have also attempted to compare two or more methods for 
determining sperm viability in stallions [2,3,14], fowl [1,15], dogs [4], and cats 
[16].   Research has also been performed in an attempt to validate or evaluate a 
single method for determining sperm concentration and sperm viability [1].   
Evaluation of sperm membrane viability using the eosin-nigrosin stain has 
been used as a field procedure in clinical practice for the assessment of sperm 
viability, as it is simple, quick, and only requires a light rather than a fluorescent 
microscope.  However, to our knowledge, no information is available on the 
correlation of viability findings with eosin-nigrosin to that determined by flow 
cytometry of SYBR-14/PI stained sperm.  Although the accuracy and 
repeatability of the flow cytometer are unrivaled, the cost and skills involved in 
using this instrument make it impractical for most laboratories and breeding 
farms.  Another potentially objective method for determination of sperm 
membrane viability, assessment of propidium iodide staining using the 
NucleoCounter® SP-100TM, is available.  The NucleoCounter SP-100 
determines total sperm concentration by permeabilizing the sperm using 
Reagent S-100 and then staining with PI; to evaluate viable sperm, this total 
concentration is compared to the concentration (number of PI-stained sperm) 
detected when a separate aliquot of the semen sample is diluted in phospate-
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buffered saline and PI is allowed to permeabilize sperm membranes that are 
already damaged.    
The objective of this study was to compare the accuracy and repeatability 
among three different methods for assessing equine sperm viability (eosin-
nigrosin, flow cytometer, and NucleoCounter® SP-100TM).  Throughout this 
thesis, sperm that are said to be viable are defined as sperm having plasma 
membranes that are intact. The effects of different concentrations of seminal 
plasma on sperm motion characteristics using a computer assisted sperm 
motion analyzer (CASMA) and viability staining using each method was 
assessed.  Two instruments, the FACScan flow cytometer (Becton-Dickinson 
Immunocytometry Systems, San Jose, CA) and the NucleoCounter® SP-100TM 
(Chemometec A/S, Allerød, Denmark) utilize fluorescent probes as a means for 
determining sperm membrane viability.  Eosin-nigrosin (Lane Manufacturing, 
Inc., Denver, CO) is an exclusion stain, a method to stain sperm if the sperm 
plasma membranes have been disrupted, and viability is assessed by counting 
sperm that exclude stain using light microscopy.  Sperm that uptake eosin 
display a pink sperm head and are counted as non-viable, whereas sperm that 
remain white indicate an intact sperm membrane.  Sperm motion characteristics 
were obtained using a computer-assisted sperm motion analyzer (CASMA; 
IVOS Version 12.2L, Hamilton Thorne Biosciences, Beverly, MA, USA). 
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1.1.  Background 
1.1.1.  Seminal plasma 
Seminal plasma is composed of proteins, enzymes, electrolytes and trace 
elements produced by the testes, epididymides and the accessory sex glands 
[17].  Seminal plasma is an alkaline buffer and is thought  to play a role in 
suppressing the uterine inflammatory response to insemination [18-20], and 
motility initiation, sperm capacitation and the acrosome reaction [21, 22].  No 
matter the breeding technique, the presence of seminal plasma at some level 
may be essential for cooled storage of extended semen with most milk-based 
extenders [6, 23-28]. 
Pickett et al. in 1975 studied the effects of seminal plasma level (0% - 
50%) on equine sperm motility during incubation before and after 
cryopreservation using a skim-milk extender, as well as the effects of 
centrifugation [27].  These authors found that regardless of treatment, maximal 
sperm motility was found in 20% seminal plasma.  Complete seminal plasma 
removal decreased motility significantly (P<0.05) before and after 
cryopreservation [27].  
In contrast other studies reported that seminal plasma removal improved 
sperm motion characteristics specifically when a modified Tyrode’s extender 
was used, suggesting that extender type and seminal plasma level may interact 
to maintain sperm membrane viability and motility [11, 29, 30].  Padilla and 
Foote in 1991 compared sperm motion characteristics of stallion semen 
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subjected to one of four treatments after cooled-storage (4°C) for 24, 48, and 72 
hours [30].  Treatments compared seminal plasma diluted in either a traditional 
nonfat dry skim milk extender (Kenney type) or a modified Kenney extender with 
Tyrode’s added (KMT) [30].  When seminal plasma was removed, sperm motion 
characteristics were superior (P<0.05) in the modified Kenney extender (KMT).  
Rigby et al. in 2001 found that fertility was not compromised in normal mares 
when a skim milk-glucose extender with added Tyrode’s medium was used for 
cooled semen storage for 48 hours prior to insemination [29].  Rigby et al. also 
reported that using a skim milk-glucose extender with added Tyrode’s solution 
(KMT: 35%) was inferior to straight skim milk-glucose extender (Kenney type) for 
storage of uncentrifuged semen for cooled transport when the seminal plasma 
was 20% [29].  Consistent with other studies, Rigby et al. found that the 
presence of seminal plasma with modified Tyrode’s extender was detrimental to 
the sperm motion characteristics after cooled-storage [30, 31].  Akcay et al., 
2006 demonstrated that seminal plasma from different fractions of an ejaculate 
had different effects on viability and motion characteristics of stallion sperm 
compared to seminal plasma harvested from the total ejaculate.  Seminal 
plasma from the sperm-poor fraction of the ejaculate maintained better sperm 
motion characteristics and higher sperm membrane integrity during cold-storage 
conditions when compared to seminal plasma harvested from the sperm-rich 
fraction of the ejaculate [11].  Similar to Padilla and Foote, and Rigby et al., 
Akcay et al. also found that seminal plasma was detrimental to the longevity of 
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cooled-stored sperm extended in KMT when sperm motion characteristics were 
assessed, indicating that extender type and the presence or absence of seminal 
plasma should be considered when processing stallion semen.  Akcay et al. 
found that removing the seminal plasma and resuspending the sperm in KMT 
resulted in better motion characteristics when compared to the treatments with 
seminal plasma in extender with and without added Tyrode’s [11].  Jasko et al. in 
1992 found that removing seminal plasma completely had a detrimental effect 
(P<0.05) on total sperm motility after 24-hour cooled storage when a nonfat, 
dried skim milk – glucose extender (E –Z Mixin K, Animal Reproduction 
Systems, Chino, CA) was used to extend the semen [6].  Brinsko et al. in 2000 
also found that partially removing seminal plasma (~90%) from an ejaculate by 
centrifugation compared to routine processing (three parts extender: one part 
neat semen) improved the progressive motility of cooled-stored semen after 24 
and 48 hours in stallions that were considered “poor-cooling” [8].  “Poor-cooling” 
stallions were those that showed a ≥ 40% decrease in progressive motility as 
compared to fresh after 24 hours of cooled-storage [8].  Other studies 
demonstrated that a small percentage (5%-20%) of seminal plasma should be 
included when extending semen to maintain sperm motion characteristics and 
sperm membrane integrity [5, 6].  Seminal plasma, at most 20%, has been found 
to be essential for sperm motility if sperm were suspended in skim-milk glucose 
extender [5, 6].  Seminal plasma could be eliminated if sperm are suspended in 
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KMT extender, and in fact, elimination of seminal plasma in semen extended in 
KMT results in greater longevity of motility [11]. 
Previous studies have used the addition of dead sperm (intentionally 
frozen-thawed multiple times) to create sperm populations with different 
viable/non-viable ratios for testing of viability measures [2,13], however, to our 
knowledge, there have been no reports on research using varying seminal 
plasma levels to induce potentially different viable and non-viable sperm ratios.  
This approach uses a physiologic inducer of non-viability rather than a more 
severe non-physiologic method such as freezing and thawing. The research 
reported in this thesis utilized four treatments with varying percentages of 
seminal plasma and sperm concentrations (80SP – semen diluted to 80% 
seminal plasma; 80SP/20 – semen diluted to 80% seminal plasma thus 
containing 25% the sperm concentration as 80SP; 50SP – semen diluted to 50% 
seminal plasma thus containing 62.5% (⅝) the sperm concentration as 80SP; 
20SP – semen diluted to 20% seminal plasma thus containing 25% the sperm 
concentration as 80SP) using un-centrifuged, neat semen diluted with extender 
or with extender with added seminal plasma.  Measurements were obtained 
following 0 h, and at 24, and 48 hours of cooled storage.  Increasing 
concentrations of seminal plasma were used in this study to induce sperm 
quality deterioration over time and create a range of membrane-damaged (non-
viable) sperm to facilitate evaluation of the sperm quality measurement methods. 
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1.1.2. Methods for detecting sperm viability 
 Several studies have assessed different methods for determining sperm 
membrane viability [1-4, 9, 13-16, 32-37].  Most methods evaluate the condition 
of the sperm plasma membrane based on the ability of a non membrane-
permeable dye to gain access to the sperm.  Propidium iodide (PI) and eosin 
stain can access sperm only if the sperm plasma membrane is damaged.  The 
dye, SYBR-14, penetrates the sperm plasma membrane regardless of its sperm 
membrane integrity, and so can be used to determine the total number of sperm.  
When used in combination with propidium iodide the SYBR-14 stain will be over-
colored by PI in those sperm that are non-viable, but will not mark viable sperm, 
since PI will not penetrate the viable sperm membrane. The assumption that 
intact plasma membranes would prevent dyes such as eosin and propidium 
iodide from entering the cytoplasm was first addressed in using the cytosolic 
stain eosin and nigrosin [32-34].  Eosin is a cytosolic stain that enters disrupted 
plasma membranes and dyes the cytoplasm within the plasma membrane 
thereby marking these sperm cells with a bright pink color.  Nigrosin is used as a 
background stain to assist in detection of the sperm cells that do not uptake 
eosin.  Figure 1 shows the contrast between sperm that show eosin uptake 
(pink) or exclusion (white). 
 The use of eosin-nigrosin as a stain for detecting dead sperm was first 
studied by J. L. Hancock in 1951 in semen obtained from bulls.  He found that as 
bull sperm were subjected to temperature shock (30°C – 0°C), the proportion of 
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stained (“dead”) sperm increased as the temperature decreased (N = 6 
ejaculates) [32]. 
 
 
 
Figure 1.  Sperm sample stained with eosin-nigrosin.  The sperm on the top did 
not uptake eosin and is counted as viable (membrane intact).  The sperm on the 
bottom did uptake eosin and is counted as non-viable (membrane not intact).  
The black background is due to the nigrosin stain. 
  
 
Campbell et al. (1956) conducted experiments on ram, bull, and boar 
semen using eosin-nigrosin and light microscopy to evaluate “live “ and “dead” 
sperm.  Measuring sample and subsample variation, and comparing different 
methods of preparation and counting techniques, he suggested the following 
guidelines: 1) sperm should be exposed to the stain for a minimum of 5 minutes; 
2) microscopy fields for evaluation should be chosen at random; 3) expect larger 
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variation among counts when sperm clumping is present; 4) establish a well-
defined interpretation of “stained” versus “unstained” sperm [33]. This 
interpretation was followed in this study by counting partially stained sperm 
separately from dead and live sperm [33].  Partially stained sperm were sperm 
that held a grayish color instead of white or pink, or those whose sperm heads 
were stained pink on the anterior portion but showed no stain on the posterior 
portion [33].  The clumping that was mentioned in the third guideline, and 
visualized more frequently when the experiments were performed on ram sperm, 
was thought to have accounted for the increase in “dead” sperm because a 
higher percentage of stained sperm were seen in clumps compared to the rest of 
the microscopic fields [33].  These findings are not entirely suggestive that dead 
sperm clump together, but that sperm that lie close together are more likely to 
look stained because eosin-nigrosin stain will be thicker in these areas [33].  
Findings from other research have revealed that dead sperm have a tendency to 
clump together interfering with assessment of stained versus unstained sperm 
[35].  When eosin-nigrosin is used, a technician effect is likely due to variability 
in performing the staining procedure, including the amounts of stain and semen 
used, the methods for mixing the stain and semen, the pressure and methods 
used to make the slide smear, choice of areas to evaluate, and interpretaion of 
the staining results.  Because viability is determined objectively by visual 
assessment, counting and assigning “stained” or “unstained” to sperm that are 
grouped in clumps could prove difficult to the human eye.  When the cells lie on 
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top of each other, mistakes can be made in determining whether they are 
stained and sperm can be missed in the count.  Dott and Foster (1972) 
conducted an experiment comparing the assessment of eosinophilic and non-
eosinophilic sperm cells with eosin and 5 g of nigrosin (EN) or 10 g nigrosin 
(NE), and with or without clearing (immersion in aniline blue).  Results indicated 
that both concentration of nigrosin and clearing affected the results, which was 
explained by the occurrence of partially stained sperm [33, 34, 36]. By the 
definition of the method by which eosin-nigrosin works, it can be assumed that 
partially stained sperm are sperm in which some form of plasma membrane 
damage has occurred; therefore, we chose to classify any level of pink staining 
of eosin as a membrane damaged cell. 
Many of these earlier studies focused on examining the technique of 
using eosin-nigrosin; it was difficult to validate its use as a reliable method for 
determining sperm viability because there was no accepted standard to which to 
compare it [33-36].  More recent studies have compared eosin-nigrosin to other 
sperm viability tests [9, 14-16, 37].  Pintado et al. (2000) compared the use of 
eosin-nigrosin, Hoechst 33258, PI, and Hoechst 33258 with PI in bull and boar 
sperm.  Propidium iodide (PI) is a membrane impermeant fluorescent stain that 
stains DNA and is excited by 488 nm wavelength of light.  Because PI only 
enters cells with damaged membranes, it is commonly used as a test for non-
viability.  Hoechst 33258 is also a fluorescent dye that stains DNA and is excited 
by 350 nm wavelength of light.  Hoechst 33258 is a membrane-permeant dye 
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and is more lipophilic when compared to PI therefore it is able to enter intact 
sperm membranes as well as non-intact sperm membranes, and relative 
staining is dependent upon the concentrations of Hoechst 33258 used.  Visual 
assessment under light and fluorescent microscopy was used in the analysis of 
all four methods in the study conducted by Pintado et al.  The eosin-nigrosin 
protocol employed in this study had added Giemsa despite the findings of 
preliminary studies done by the same group that recorded that the number of 
non-viable cells were not different when comparing eosin-nigrosin used alone 
and eosin-nigrosin used with Giemsa [37].  Three experiments were conducted 
to determine the correlations between the three methods of assessing sperm 
viability using fresh semen from boars (Experiment 1), boar semen with dead 
sperm added (Experiment 2), and frozen bull semen (Experiment 3).  When 
samples from fresh boar semen were analyzed (Experiment 1), a high 
correlation was found among all methods; however, the highest correlation 
(R=0.964: P<0.01) was found between the PI and Hoechst stains [37].  When 
dead spermatozoa were added to fresh boar ejaculates (Experiment 2), 
correlations were lower (R=0.727, P<0.01) with PI showing a higher number 
(66.4 ± 2.4%) of stained (non-viable) cells than did either eosin-nigrosin (56.9 
±1.84%) or Hoechst 33258 (60.1 ±1.66%) [37].  Similarly, when frozen-thawed 
bull semen was evaluated, (Experiment 3), PI labeled a higher number of cells 
(P<0.05) compared to the other methods [37].  Pintada et al. concluded that PI 
consistently stained more non-viable sperm, and that the method type used for 
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determining sperm viability may influence the final value.  In addition, Pintada et 
al. suggested that species type may also affect the results since Hoechst 33258 
and eosin-nigrosin were more highly correlated in bull sperm (R=0.80; 
P=0.0017) than in boar sperm (R=0.84: P=0.0007 for Exp. 1; R=0.38; P=0.219 
for Exp. 2) [37].   
 Viability results with eosin-nigrosin have also been compared to those 
obtained with a combination of the fluorescent dyes SYBR-14 and PI, using light 
(eosin-nigrosin) and fluorescent (SYBR-14) microscopy [15].  SYBR-14 is a 
membrane-permeant nucleic acid stain and therefore stains the DNA of all cells. 
It is excited by 522 nm of laser light.  When used together with fluorescent 
microscopy or a flow cytometer, SYBR-14 and PI can allow the researcher to 
rapidly and definitively distinguish between non-viable and viable cells in a 
population.  SYBR-14-stained sperm (viable) fluoresce green, and SYBR-14/PI-
stained sperm (non-viable) fluoresce red (Figure 2). 
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Figure 2.  Equine sperm that have been treated with SYBR-14 and PI and 
analyzed using fluorescent microscopy.  The green (SYBR-14) sperm head is 
considered viable and the red (SYBR-14/PI) is considered non-viable. 
 
Chalah et al. assessed sperm viability in fowl sperm at 0, 0.5, 2, 4, and 24 
hours of storage at 40C and after frozen semen had been thawed.   Membrane 
viability of the samples stained with eosin-nigrosin was assessed visually using 
light microscopy.  Membrane viability of the samples stained with the dual 
fluorescence (SYBR-14/PI) was assessed using a pre-scaled 
spectrophotometer.  In this study, Chalah et al. found that the dual fluorescence 
of SYBR-14/PI using the spectrophotometer was a more efficient method for 
determining sperm membrane viability when compared to eosin-nigrosin staining 
(P<0.05) in fresh fowl ejaculates at Time 0 and Time 30 minutes indicating that 
SYBR-14/PI is a faster staining technique than eosin-nigrosin [15].  In 
cryopreserved samples, the two staining methods for sperm membrane viability 
were not significantly different if viability was assessed immediately after the 
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samples were thawed [15].  However, when sperm was assessed after 4 hours 
of cooled storage post-thaw, SYBR-14/PI stained samples showed a 
significantly higher (P<0.05) number of non-viable sperm when compared to the 
eosin-nigrosin. Chalah et al. concluded that the dual fluorescence of SYBR-
14/PI is a quicker and more effective method for determining sperm viability in 
fowl [15]. 
 Assessment of sperm viability using a new method, the NucleoCounter® 
SP-100TM , is based on a computerized method of fluorescent microscopy 
whereby sperm is diluted in detergent to obtain total sperm concentrations or 
phosphate-buffered saline to obtain non-viable sperm concentration and 60µL of 
this sample is aspirated into a cassette containing a flow system laced with 
propidium iodide (PI).  The PI in the cassette is dissolved by this mixture and 
sperm with disrupted plasma membranes uptake the PI and emits red 
fluorescence that is detected by the NucleoCounter® SP-100TM.  The only study 
known to us comparing the sperm membrane viability function of the 
Nucleocounter® SP-100™ to another method of determining sperm membrane 
viability was conducted by Johansson et al. in 2008 [14].  This study compared 
equine sperm membrane viability assessed using eosin-nigrosin staining to that 
obtained using the Nucleocounter® SP-100™ in eight ejaculates from nine 
stallions.  This study also attempted to correlate membrane viability with sperm 
motion characteristics (progressive motility).  Findings from this study included: 
1) the eosin-nigrosin staining technique consistently showed a higher population 
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of viable cells when compared to the Nucleocounter® SP-100™ 2) the mean 
difference in sperm membrane viability between the two methods was 12.5%, 
however this difference was not statistically significant (P = 0.09; R = 0.64), and 
3) sperm membrane viability assessed with both methods correlated highly with 
progressive motility (R=0.72 with eosin-nigrosin staining; R=0.79 with 
NucleoCounter SP-100) [14]. 
 The objectives of this thesis research were to compare three methods for 
detecting membrane viability of equine sperm, and the effects of seminal plasma 
on sperm membrane viability and motion characteristics.  The three methods 
were flow cytometry using SYBR-14/propidium iodide, eosin-nigrosin staining, 
and the NucleoCounter® SP-100TM .   
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2. MATERIALS AND METHODS 
Semen was collected using an artificial vagina (Missouri-model; Nasco, 
Ft. Atkinson, WI, USA) fitted with a nylon micromesh filter (Animal Reproduction 
Systems, Chino, CA, USA) to remove gel and debris from the ejaculate.  The 
stallions were mature (age 9 to 20 years old) and sexually active.  Stallions were 
collected daily for 2 to 3 days then allowed a 48-hour period of sexual rest prior 
to collection of an ejaculate for the experiments.  A mare in estrus or an 
ovariectomized mare was used for sexual stimulation and a breeding phantom 
was used as a mounting source for the stallion.  The penis was washed 
thoroughly with water and dried while erect immediately prior to collection.  The 
artificial vagina was lubricated with a small volume (3 to 5 mL) of sterile non-
spermicidal lubricant (Priority Care, First Priority, Inc., Elgin, IL, USA) before the 
semen was collected.   
2.1.  Semen processing 
After collection the semen was taken to an adjacent laboratory and 
evaluated for: volume (using a graduated cylinder); concentration as determined 
by the NucleoCounter® SP-100TM; viability as determined by the 
NucleoCounter® SP-100TM and eosin-nigrosin stain; and for sperm motion 
characteristics using a computer-assisted sperm motion analyzer (CASMA; 
IVOS Version 12.2L, Hamilton Thorne Biosciences, Beverly, MA, USA). 
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2.2.  Seminal plasma processing 
 One to two ejaculates were collected from each of three stallions used in 
the experiments to obtain sperm-free seminal plasma.  The semen was collected 
as previously described, and the raw semen was placed in two 15mL BLUE 
MAX™ polypropylene conical tubes (Becton Dickinson Labware, Franklin Lakes, 
NJ, USA).  The semen was centrifuged (IEC Centra CL@; Thermo Scientific, 
Waltham, MA, USA) for 10 minutes at 2000 x g.  The supernatant (seminal 
plasma) was aspirated off of the pellet (sperm) using a plastic 1 mL transfer 
pipette (Samco Scientific, Mexico) and transferred to a 15 mL syringe equipped 
with a 1.2 micron and 5.0 micron nylon filter (Cameo 30N Syringe Filter, Nylon, 
30 mm; SIGMA-ALDRICH, St. Louis, MO, USA).  These filters served to remove 
any sperm still remaining in the seminal plasma.  The seminal plasma was 
filtered through the nylon filters into a separate conical tube. Aliquots (1.2 mL) of 
seminal plasma were placed in micro tubes  (disposable/conical economy micro 
tubes with snap caps [1.5 mL]; VWR International, USA) and stored in a freezer 
at -80°C until used.   
  2.3.  Eosin-Nigrosin slide preparation and analysis 
 Slides (Bev-l-edge Micro Slides; pre-cleaned; twin-frost; Propper 
Manufacturing Co., Inc., Hungary) were placed on a warmer for several minutes.  
The slides were labeled with the appropriate treatment, time, and replicate 
number.  Slides were removed from the warmer and 15 µl of eosin-nigrosin stain 
was placed ¼ inch from the frosted section of the slide using a pipetter.  Ten µL 
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of the semen sample from the treatment tube was dispensed into the eosin- 
nigrosin stain and the mixture was stirred five times with the pipette tip.  A 
separate slide was held at a 45° angle and used to gently streak the sample 
mixture.  The slide was placed back on the warmer for several minutes to allow 
the stain mixture to dry and then placed in a slotted slide box and evaluated 
within the next 48 hours.  A total of 300 sperm were classified according to 
staining.  Sperm that did not uptake the stain (remained white) were counted as 
viable and sperm that did uptake the stain (turned pink) were counted as non-
viable sperm, using percentage to determine viability.  Sperm were classified as 
non-viable if they exhibited any uptake of eosin therefore partially stained sperm 
were counted as non-viable. 
2.4.  Flow cytometry (SYBR-14/propidium iodide staining) 
 Treatment samples were prepared using the protocol from the 
LIVE/DEAD® Sperm Viability Kit (L-7011) (Molecular Probes, Inc., Eugene, OR)  
with a few modifications.  The kit utilizes a prepared working solution of SYBR-
14 previously diluted in sterile dimethyl sulfoxide (DMSO; SIGMA-ALDRICH, St. 
Louis, MO; USA) or a buffer to yield SYBR-14 working solution concentrations of 
100 µM or 20 µM, respectively, and PI at a concentration of 2.4 mM as a stain 
for sperm non-viability.  The protocol from the manufacturer recommends that 
the SYBR-14 dye concentrate (stock solution) be diluted 10-fold in DMSO, with 5 
µl of this SYBR-14 working solution subsequently added to 5 mL of extended 
semen, thereby yielding a final SYBR-14 concentration of 0.1µM.  The sample 
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was to be incubated for 10 minutes at 37°C before the addition of 25 µL of PI 
solution to give a final PI concentration of 12 µM.  The tube was to be vortexed 
gently for three seconds after the addition of PI.  The manufacturer 
recommended an additional 5 minute incubation at 37°C before analysis.  For 
the current project, the volumes of SYBR-14, PI, and extended semen were 
immediately reduced to half the original volumes: this allowed use of less 
material while concentrations of SYBR-14 and PI were maintained at the level 
recommended by the manufacturer.  The protocol was later modified based on 
the results of Experiment 2 and Experiment 3. 
Prior to flow cytometric analysis a designated volume of the treatment 
sample, which varied dependent on sperm concentration as described below 
(Table 1), was combined with 500 µL of Garner’s solution (130 mM NaCl, 40mM 
KCl, 14 mM Fructose, 10 mM Hepes, 1 mM CaCl2, 0.2 mM MgCl2, Bovine 
Serum Albumin V 1 mg/mL, pH7.38).  The table (Table 1) was formulated based 
on a preliminary project conducted in the laboratory to determine the appropriate 
volume of semen to add to the 500 µL of Garner’s solution to allow for an 
events-per-second count of 200 to 500 when processed on the flow cytometer.  
The volume was dependant upon the sperm concentration of the semen sample. 
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Table 1.  Volume of the semen sample, dependent on sperm concentration, 
added to the flow cytometer tube containing 500 µL of Garner’s solution. 
 
Sperm concentration (million/mL) Volume of treatment sample (µL) 
< 15 10.0 
16-30 5.0 
31-59 2.5 
60-79 2.0 
80-250 1.0 
>250 0.5 
 
 
This sample was allowed to equilibrate for 30 seconds before being evaluated 
by flow cytometric analysis (FACScan Analyzer flow cytometer (Becton-
Dickinson Immunocytometry Systems, San Jose, CA).  Flow cytometric data 
was stored in List-mode until analysis. A total of 5000 cellular events were 
evaluated per sample at a rate of between 200 to 500 cells/second and the 
percentages of viable and non-viable sperm were determined using WinList™ 
software (Verity Software House, Topsham, ME, USA).  
2.5.  NucleoCounter® SP-100TM(propidium-iodide staining)    
 Total sperm concentration was determined by adding Reagent S-100 
(Chemometec A/S, Allerød, Denmark) at appropriate dilution factor volumes to 
Cryogenic vials ([1.2 mL and 2.0 mL]; Corning Life Sciences, Lowell, MA, USA), 
Reagent S-100 is a detergent that is designed to disrupt all plasma membranes 
and allows PI to label DNA in all sperm in the sample. The non-viable sperm 
concentration was determined by substituting phosphate-buffered saline 
(GIBCO® Dulbecco’s Phosphate Buffered Saline 1X; Invitrogen; Grand Island, 
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NY, USA) for Reagent S-100.  Dilution factors were prepared according to a 
manufacturer recommended dilution table (Table 2).  
 
 
Table 2.  Manufacturer recommended (Chemometec A/S, Allerød, Denmark) 
dilution table. 
 
Sperm 
concentration 
(million/mL) 
Dilution Factor Diluent volume (µL) Semen volume (µL) 
<8 6 500 100 
8-70 11 1000 100 
15-125 21 1000 50 
25-300 51 1000 20 
50-700 101 1000 10 
100-1400 201 2000 10 
200-2500 401 4000 10 
 
 
Each treatment sample was mixed thoroughly and a specific sample volume was 
added using a positive displacement pipette.  The sides of the pipette tip were 
wiped with a Kim-Wipe® to remove any excess sperm before the sample was 
dispensed into the solution.  The cryovial was inverted 10 times prior to analysis.  
An SP1-Cassette (Chemometec A/S, Allerød, Denmark) was used to determine 
total and non-viable concentrations (one cassette/tube).  The total concentration 
was assessed immediately prior to determining the non-viable concentration for 
each replicate to allow the SemenView™ program (Version 1.21; Chemometec 
A/S, Allerød, Denmark) to calculate the percent viable cells.   The percentage of 
viable cells was calculated using the SemenView™ program, or by hand 
calculations using the following equation supplied by Chemometec: Viability (%) 
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= 100% * [(TOTAL – NON-VIABLE)/TOTAL)].  In order for the SemenView™ 
program to calculate the viability of the sample, the total concentration and non-
viable concentration must be run consecutively with the total concentration first.  
If an error occurred during data collection and the counts became out of 
sequence, the viability was calculated by hand. 
2.6.  Sperm motion characteristics (CASMA) 
 A small aliquot of the treatment sample was extended (~25 million/mL) in 
prewarmed (37°C) INRA 96 (GlaxoSmithKline, Research Traingle Park, NC, 
USA) or INRA 96 with 1 mg/mL added of Timentin (INRA-T) and aliquoted into 
0.6 mL microcentrifuge tubes with a flat cap (Fisher Scientific; Pittsburgh, PA, 
USA).  These tubes were either used for immediate anlaysis or were placed in 
an Equitainer® I for later analysis.  For analysis, the microcentrifuge tube was 
placed on a slide warmer and allowed to warm for 10 minutes.  Six µl of the 
contained sample was loaded onto warmed (37°C) analysis chambers fixed to 
microscope slides (Leja Standard Count 2 Chamber slides; Laja Products, B.V., 
Nieuw-Vennep, The Netherlands).  The slide was placed onto a warmed stage 
and inserted into the CASMA.  A minimum of 10 microscopic fields and 500 
sperm were analyzed per sample.  Preset values for the IVOS system consisted 
of the following: frames acquired – 45; frame rate – 60 Hz; minimum contrast – 
70; minimum cell size – 4 pixels; minimum static contrast – 30; straightness 
(STR) threshold for progressive motility – 50; average path velocity (VAP) 
threshold for progressive motiliy – 30; VAP threshold for static cells – 15; cell 
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intensity – 106; static head size – 0.60 to 2.00; static head intensity – 0.20 to 
2.01; static elongation – 40 to 85; LED illumination intensity – 2200.  Each 
replicate performed was extracted from the same microcentrifuge tube prepared 
for the CASMA.  Motility parameters assessed and of importance to this study 
were total and progressive sperm motility. 
2.7.  Statistical analyses 
Percentages of non-viable and viable sperm obtained from the three 
methods for assessing sperm membrane viability, and the total sperm motility 
obtained from the CASMA were converted from percentage to decimal points.  A 
general linear model was utilized using SAS® (Statistical Analysis Software).  
Percentage-data was transformed to its arc sin square root.  Analysis of 
variance (ANOVA) was used to evaluate the main effects of treatment, time, and 
treatment x time interaction.  Means for the coefficients of variation from the 
transformed data were calculated to determine method repeatability.  In addition 
to the statistical methods discussed above, in Experiment 6, Bland and Altman 
plots were used to determine method agreement between the flow cytometer, 
NucleoCounter® SP-100TM, and eosin-nigrosin staining.  Bland and Altman plots 
were also prepared to determine any agreement between total motility (TMOT) 
using CASMA and sperm membrane viability using the three methods. The limits 
of agreement were calculated and graphed based on literature published by 
Bland and Altman [38, 39].  Association between methods was further described 
using simple regression on untransformed data and compared to the line of 
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equality.  All equations and their associated values as well as the absolute 
values of the differences between methods were also reported.  
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3. EXPERIMENTAL DESIGN WITH RESULTS AND DISCUSSION 
3.1.  Experiment 1:  Comparison of SYBR-14 working solution protocols 
 Experiment 1 was conducted to determine the best method for preparing 
the SYBR-14 working solution to be used for evaluation of sperm membrane 
viability by flow cytometry.  Specifically, since the different working solutions also 
had varying levels of DMSO, this experiment measured the effect of 
concentrations of DMSO (%V/V), on sperm membrane viability.   
The LIVE/DEAD Sperm Viability Kit recommends two different dilutions 
for preparing the SYBR-14 working solution (dilution in DMSO or a buffer).  The 
SYBR-14 stock solution is packaged as 100 µL of a 1 mM solution in 100% 
DMSO.  The PI solution is packaged as 5 mL of a 2.4 mM solution in water.  For 
this study a total of 4 dilutions were prepared (Treatments 1 to 4): 1) SYBR-14 
stock soloution was diluted 50-fold in Garner’s solution yielding a 2% DMSO and 
a 20 µM SYBR-14 working solution.  This solution was prepared fresh before 
each ejaculate; 2) SYBR-14 stock solution was diluted 10-fold in DMSO yielding 
a 100% DMSO and 100 µM SYBR-14 working solution.  This solution was 
stored at -80°C and thawed before use; it was reused a maximum of one time; 
3) SYBR-14 stock solution was diluted 5-fold in DMSO yielding a 100% DMSO 
and 200 µM SYBR-14 working solution concentration.  This solution was stored 
at -80°C and thawed before use; it was reused a maximum of one time; 4) 
SYBR-14 stock solution was diluted 5-fold in PBS yielding a 20% DMSO and 
200 µM SYBR-14 working solution.  This solution was prepared fresh for each 
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ejaculate.  These SYBR-14 working solutions are referred to as Treatments 1 to 
4 (Table 3). 
 
 
Table 3.  Four different protocols for preparing the SYBR-14 working solution 
from the stock solution (1mM SYBR-14 in 100% DMSO) including treatment 
number, dilution ratio, diluent, DMSO concentration (%V/V), and concentration 
of SYBR-14. 
 
Treatment Dilution Diluent % DMSO [SYBR-14] (µM) 
1 50 fold Garner’s 2 20 
2 10 fold DMSO 100 100 
3 5 fold DMSO 100 200 
4 5 fold PBS 20 200 
    
 
 A single gel-free ejaculate was collected and processed as described 
above.  The semen was extended to approximately 25 x 106 sperm/mL in INRA-
96.  After the addition of SYBR-14 solutions to the semen sample, the tubes 
were incubated for 10 minutes at 37°C and then PI was added, followed by an 
additional 5 minute incubation at 37°C.  The tubes were prepared using the four 
volumes of semen and SYBR-14 working solutions as given in Table 3.  The 
DMSO concentration (%V/V), concentration of SYBR-14 and concentration of PI 
within each treatment tube was calculated after being added to the semen 
sample and the results are given in Table 4.  The samples were prepared then 
analyzed on the flow cytometer using the protocol described in the materials and 
methods at zero, 10, and 20 minutes.  Two replicates were performed for each 
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treatment at each time interval for a single ejaculate.  Percentage of sperm 
assessed as viable or non-viable were compared among treatments.    
   
Table 4.  Volumes of semen, concentration of DMSO (%V/V), and final 
volumes/concentrations of SYBR-14 working solution and PI used with the 
SYBR-14 working solutions (Treatments 1-4) in preparation for analysis using 
flow cytometer. 
 
Tube SYBR-14 
treatment 
Semen 
(µL) 
SYBR-
14 (µL) 
[SYBR-
14] (µM) 
PI  
(µL) 
[PI]  
(µM) 
% 
DMSO 
1 1 1000 5 0.1 5 12 0.01 
2 2 2500 2.5 0.1 12.5 12 0.1 
3 3 150 20 26.6 36 576 2.6 
4 4 150 20 26.6 36 576 13.3 
 
 
3.1.1.  Results:  Experiment 1:  Comparison of SYBR-14 working solution 
protocols 
 Mean percent viable sperm was similar for Treatments 1 and 2 (75.24% 
and 74.73%, respectively, P>0.05) but was lower for Treatments 3 and 4 (59.3% 
and 38.6%, respectively, P=0.004) with increasing DMSO concentrations (%V/V) 
(Figure 3). 
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Figure 3.  Effect of DMSO concentration (%V/V) on sperm assessed as viable by 
flow cytometry (n=2 replicates, values for three assessment times was 
combined) with standard deviation error bars. 
  
 
3.1.2.  Discussion:  Experiment 1:  Comparison of SYBR-14 working solution 
protocols  
 Results from this experiment were in agreement with other studies [40-42] 
in that DMSO at levels such as 1.0 M [40, 42], and 1.5%-3% (v/v) [41], caused 
increased permeability of the sperm plasma membranes.  Experiment 1 was 
conducted to determine which SYBR-14 working solution to use in the remaining 
experiments, and results indicated that the protocols (Treatment 1 and 
Treatment 2) from the LIVE/DEAD Sperm Viability Kit were superior when 
compared to the experimental protocols (Treatment 3 and Treatment 4) for 
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determining the membrane viability of sperm, with the assumption that the 
higher value for viability was the correct on.  Standard deviation was greater in 
Treatments 3 and 4.  Data from Times 0, 10, and 20 minutes were combined in 
Figure 1 and values for sperm membrane viability decreased as incubation time 
increased.  Treatment 2 was chosen as the protocol to be used for the remaining 
experiments due to the manufacturer’s recommendation that if the SYBR-14 
stock solution was diluted in DMSO it could be re-frozen and used at a later 
date.  This recommendation (re-use after freezing) was not validated 
experimentally until a later preliminary study (Experiment 4), therefore the 
SYBR-14 working solution, using Treatment 2, was prepared fresh for each 
ejaculate in Experiments 2 and 3. 
3.2.  Experiment 2:  Comparison of SYBR-14 working solution volumes and 
incubation times   
 To assess the difference in the staining of the DNA of the sperm at 
different volumes of SYBR-14 (0.5 µL, 1.0 µL, 2.5 µL) added to a 2.5-mL aliquot 
of semen, thus resulting in solutions with 0.02 µM, 0.04 µM and 0.1 µM SYBR-
14 and 0.04%, 0.02%, and 0.1% DMSO, respectively (Table 5), and to 
determine if incubation time (15 minutes, 16.5 minutes, 18 minutes) affected the 
recorded membrane viability of the sperm, one ejaculate from each of three 
stallions was collected as previously described and extended to approximately 
25 x 106 sperm/mL in INRA 96 to a total volume of 100 mL and placed in two 50 
mL conical tubes.  SYBR-14 was diluted 10 fold in DMSO (Treatment 2, 
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Experiment 1).  This working solution was prepared immediately before each 
stallion was collected and stored away from direct light until needed.  The final 
SYBR-14 concentrations for the three different volumes were 0.02 µM for 0.5 µL 
SYBR-14, 0.04 µM for 1.0 µL SYBR-14, and 0.1 µM for 2.5 µL SYBR-14 (Table 
5).  The final PI concentration for each volume was 12 µM. 
 
 
Table 5.  The SYBR-14, DMSO and PI volumes and concentrations added to 2.5 
mL of extended semen prior to flow cytometric analysis. 
 
SYBR-14 (µL) [SYBR-14] (µM) DMSO (%) PI (µL) [PI] (µM) 
0.5 0.02 0.02 12.5 12 
1.0 0.04 0.04 12.5 12 
2.5 0.1 0.1 12.5 12 
 
 
Experiment 2 consisted of four parts (A-D) performed on the same 
ejaculate, and three replicates were performed for each part.  Part A- Three-flow 
cytometer tubes per replicate (9 tubes total) were labeled with treatment (0.5 µL, 
1.0 µL, 2.5 µL) and prepared using the protocol previously described (2.5 mL 
semen, 12.5 µL PI, and one of three SYBR-14 volumes).  Samples from different 
SYBR-14 concentration treatments were evaluated in a staggered order to 
ensure that the treatments were not run in the same order.  Order of assessment 
was:  Tube labels (SYBR-14 volume): 1-1a (0.5 µL), 1-1b (1.0 µL), 1-1c (2. µL); 
2-2a (1.0 µL), 2-2b (2.5 µL), 2-2c (0.5 µL); 3-3a (2.5 µL), 3-3b (0.5 µL), 3-3c (1.0 
µL).  Three tubes were prepared simultaneously (one tube for each different 
SYBR-14 volume).  Tubes were run on the flow cytometer continuously, 
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resulting in a mean incubation time of 15, 16.5, and 18 minutes for the first, 
second and third sets of treatments, respectively.  Part B was similar to Part A 
with one modification.  Tubes were labeled as described above and prepared 
seperately at a 2-3 minute interval to allow for an incubation time of 15 minutes 
for each treatment within replicates (all tubes incubated for no more than 15 
minutes).  Results obtained on the flow cytometer for sperm viability from Part B 
were compared to those from Part A to determine if an increase in incubation 
time (16.5 and 18 minutes) at 37°C would cause a change in the proportion of 
sperm assessed as viable.  Parts A and B were performed to test the inter-assay 
coefficients of variation between SYBR-14 volumes (µL)/concentrations (µM), 
and incubation times (minutes). 
  Parts C and D were performed to test the repeatability, or intra-assay 
coefficients of variation for SYBR-14 concentrations (µM), and incubation times 
(minutes).  Parts C and D were similar to the previous two parts (Parts A and B) 
however the tubes were run in a different order.  Three-flow cytometer 
tubes/replicate (9 tubes total) were labeled with volume (0.5 µL, 1.0 µL, 2.5 µL) 
and prepared using the protocol previously described.  Three tubes, containing 
the same SYBR-14 concentration, were incubated simultaneously prior to 
evaluation by flow cytometry.  Unlike Part A and B, the three tubes prepared per 
replicate had the same SYBR-14 volume.  Tube labels for Part C (SYBR-14 
volume): 1-1a, 1-1b, 1-1c (all 0.5 µL); 2-2a, 2-2b, 2-2c (all 1.0 µL); 3-3a, 3-3b, 3-
3c (all 2.5 µL).  In Part C tubes were run at 15, 16.5, and 18 minutes.  The 
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design for Part D was similar to Part C however the three tubes per replicate 
were prepared at 2-3 minute intervals to ensure an incubation time of 15 minutes 
for all tubes and SYBR-14 concentrations. 
3.2.1.  Results: Experiment 2:  Comparison of SYBR-14 working solution 
volumes and incubation times   
 In Experiment 2 there was no incubation-time by SYBR-14 volume 
interaction detected for sperm membrane viability as assessed using the flow 
cytometer (P>0.05).  No differences (P>0.05) in recorded sperm membrane 
viability were found between incubation times (Table 6) or between SYBR-14 
working solution volumes (Table 7) when each replicate was evaluated as a 
single observation.  There was a significant effect of stallion (P<0.05).  Inter- and 
intra-assay coefficients of variation are show in Tables 8 and 9.  The coefficient 
of variation for all observations (N=24) was 5.7%, 
 
 
Table 6.  Effect of incubation time on the percent of viable sperm using flow 
cytometer (mean ± SD). (N=72 for 15 minutes; N=18 for 16.5 and 18 minutes). 
 
Incubation Time (minutes) Mean % viable ± SD 
15 85.1a±6.4 
16.5 85.6a±6.7 
18 85.4a±6.7 
§ Percentage data (% viable) were arc sine-root transformed prior to statistical analysis.  
Original means and standard deviations are presented in the table but statistical tests 
were conducted on transformed data. 
a  Within incubation time, means with different superscripts differ (P<0.05) 
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Table 7.  Effect of SYBR-14 working solution volume on the mean percent of 
viable sperm using flow cytometry (mean ± SD) (N=36). 
 
SYBR-14 working solution volume (µL) Mean % viable ± SD 
0.5 85.3a±6.5 
1.0 85.3a±6.6 
2.5 85.1a±6.4 
§ Percentage data (% viable) were arc sine-root transformed prior to statistical analysis.  
Original means and standard deviations are presented in the table but statistical tests 
were conducted on transformed data. 
a  Within working solution volume, means with different superscripts differ (P<0.05) 
 
 
 
Table 8.  Inter-assay coefficients of variation for Part A and B for incubation time 
and SYBR-14 volume/concentration for the measurement of sperm viability 
using the flow cytometer (n=3 replicates for Part A; n=9 replicates for Part B). 
 
Part Incubation time 
(minutes) 
SYBR-14 volume (µL) Coefficient of 
Variation (%) 
A 15 
 
 
16.5 
 
 
18 
0.5 
1.0 
2.5 
0.5 
1.0 
2.5 
0.5 
1.0 
2.5 
10.6 
10.7 
11.3 
11.4 
9.7 
10.8 
10.8 
10.5 
10.1 
B 15 
 
 
0.5 
1.0 
2.5 
8.8 
9.3 
8.8 
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Table 9.  Intra-assay coefficients of variation for Part C and D for incubation time 
and SYBR-14 volume/concentration for the measurement of sperm membrane 
viability using the flow cytometer (n=3 replicates for Part C; n=9 replicates for 
Part D). 
 
Part Incubation Time 
(minutes) 
SYBR-14 volume (µL) Coefficient of variation 
(%) 
C 15 
 
 
16.5 
 
 
18 
0.5 
1.0 
2.5 
0.5 
1.0 
2.5 
0.5 
1.0 
2.5 
7.2 
7.2 
8.5 
7.5 
6.2 
7.1 
6.8 
9.3 
6.6 
D 15 
 
 
0.5 
1.0 
2.5 
6 
6 
5.7 
 
 
3.2.2.  Discussion: Experiment 2:  Comparison of SYBR-14 working solution 
volumes and incubation times   
 The results from Experiment 2 indicate that similar results for sperm 
membrane viability can be obtained when using a smaller volume/concentration 
of the SYBR-14 working solution (1.0 µL/0.04 µM, or 0.5 µL/0.02 µM) compared 
to the original protocol volume (2.5 µL/0.1 µM).  In addition, an incubation-time 
difference of three minutes had no effect on recorded sperm membrane viability 
when evaluated by flow cytometry.  In Experiment 2, a change in pattern was 
seen with the viable population (R1 in Figure 4) on the flow cytometer 
scatterplots when the volume/concentration of SYBR-14 was increased to 2.5 
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µL/0.1 µM.  It was hypothesized that this was due to a high SYBR-14 
concentration causing inconsistent sperm staining. 
 
 
 
Figure 4.  Flow cytometer scatterplots visually comparing the viable populations 
(R1) seen with 0.5 µL SYBR-14 (left) and the viable population seen with 2.5 µl 
SYBR-14 (right). 
  
 
The scatterplot of the viable population appeared elongated rather than 
round as the volume of SYBR-14 was increased to 1.0 µl and then to 2.5 µl as 
compared to a more circular shape (indicative of consistent sperm staining) with 
a volume of 0.5 µl, suggesting variation in stain uptake.  The percentages of 
viable and non-viable populations were not affected by this elongated pattern.  
The source of the elongated pattern was unknown.  A possible explanation for 
this was thought to be the increased SYBR-14 concentration alone, however, 
since the SYBR-14 solution contains DMSO, and because concentrations of 
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DMSO (%V/V) also vary in the three SYBR-14 volume treatments, another 
experiment was needed to establish the cause of the elongated pattern.  
DMSO has been known to cause changes in recorded sperm membrane 
viability as was evident in the findings of Experiment 1, and other studies have 
found DMSO to be associated with an increase in non-viable populations of 
sperm in rabbits [40], buffalo [41] and horses [42].  The three SYBR-14 
volumes/concentrations (0.5 µL/0.02 µM, 1.0 µL/0.04 µM, and 2.5 µL/0.1 µM) 
used in Experiment 2 had different concentrations (%V/V) of DMSO (0.02 %, 
0.04%, 0.1%).  Experiment 3 was performed in an attempt to determine the 
cause of the elongated pattern.        
  3.3.  Experiment 3. Effect of SYBR-14 concentration on SYBR-14 fluorescence 
intensity when DMSO concentration is held constant 
A single ejaculate was collected from a stallion as previously described.  
Neat semen was extended in INRA 96 to approximately 25 x 106 sperm/mL to a 
total volume of 150 mL.  The extended semen was then divided into three 50 mL 
conical tubes and the tubes were stored at room temperature and out of direct 
light until analysis.  Three five-tube treatment sets were pulled from a common 
50 mL conical tube.  A 2.5 mL aliquot of the semen sample was placed in each 
of five treatment tubes.  After the addition of SYBR-14, PI, and/or DMSO to the 
semen sample, samples were take from each of the five tubes for flow 
cytometric analysis in random order.  When all tubes had been sampled, a 
second set of samples was taken from the same 50 mL conical tube.  The 
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volumes added to 2.5 mL of semen were as follows: (A) 2 µL DMSO, 0.5 µL 
SYBR-14, 12.5 µL PI; (B) 1.5 µL DMSO, 1.0 µL SYBR-14, 12.5 µL PI; (C) 0 µL 
DMSO, 2.5 µL SYBR-14, 12.5 µL PI; (D) 2.5 µL DMSO, 0 µL SYBR-14, 12.5 µL 
PI; (E) 0 µL DMSO, 2.5 µL SYBR-14, 0 µL PI (Table 10).  Because the percent 
of DMSO varied in the samples prepared for Experiment 2, a designated volume 
of DMSO was added to the treatment tubes to allow for a constant 0.1% DMSO 
in each tube.  The protocol previously described was used for tube preparation, 
incubation, and analysis on the flow cytometer.  All tubes were vortexed prior to 
analysis. 
 
 
Table 10.  Treatment tube labels with volume and % DMSO, and 
volume/concentration of SYBR-14 and PI for Experiment 3. 
 
Treatment DMSO (µL) DMSO 
(%) 
SYBR-
14 (µL) 
SYBR-14 
(µM) 
PI (µL) PI (µM) 
A 2 0.1 0.5 0.02 12.5 12 
B 1.5 0.1 1.0 0.04 12.5 12 
C 0 0.1 2.5 0.1 12.5 12 
D 2.5 0.1 0 0 12.5 12 
E 0 0.1 2.5 0.1 0 0 
 
 
3.3.1.  Results: Experiment 3:  Effect of SYBR-14 concentration on SYBR-14 
fluorescence intensity when DMSO concentration is held constant 
  No differences (P>0.05) were seen between the volumes of DMSO and 
SYBR-14 working solution added to the semen and PI when membrane viability 
was assessed (Table 11).  The mean percent of viable sperm for all 
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observations (N=45) in Experiment 3 was 83.43% with a coefficient of variation 
of 1.2%.  The elongated pattern noted in the previous experiment was still 
evident when the DMSO concentration was held constant (0.1%).   
 
 
Table 11.  Effect of treatment (SYBR-14 and PI volumes) on the mean percent 
(mean ± SD) viable sperm using the flow cytometer (N=9). 
 
Tube Mean % viable ± SD 
A 83.7a±0.6 
B 83.6a±1.2 
C 83.6a±1.0 
D 83.2a±1.1 
E 83.2a±1.0 
 § Percentage data (% viable) were arc sine-root transformed prior to statistical analysis.  
Original means and standard deviations are presented in the table but statistical tests 
were conducted on transformed data. 
a  Within treatment, means with different superscripts differ (P<0.05) 
 
 
3.3.2.  Discussion: Experiment 3:  Effect of SYBR-14 concentration on SYBR-14 
fluorescence intensity when DMSO concentration is held constant 
When DMSO concentration was constant (0.1%) there was no difference 
in sperm membrane viability due to SYBR-14 volume or concentration.  The 
results in Treatment E were interesting since it contained only SYBR-14 and no 
PI.  Nevertheless, there were two distinct populations (Figure 3), one behind the 
other.  SYBR-14 is a fluorescent stain that enters sperm cells with disrupted 
plasma membranes as well as those cells with intact plasma membranes.  A 
possible explanation for the two distinct populations could be that the SYBR-14 
is leaking out of the disrupted plasma membranes of the non-viable cells (R2 in 
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Figure 5) causing these cells to fluoresce less brightly when compared to the 
sperm cells in the viable population (R1 in Figure 5).  If PI was added to this 
sample it is likely that the R2 population would take the PI stain and shift to the 
upper left location on the scatterplot. 
 
 
Figure 5.  Flow cytometer scatterplot evaluated from Tube E of Experiment 3. 
 
Because the elongated pattern was still evident in treatments containing 2.5 
µL/0.1 µM SYBR-14 when DMSO was held constant (0.1%), it can be concluded 
that the probable source for the elongated pattern noted in Experiment 2 was the 
increase in the concentration of SYBR-14 alone.  As more stain is introduced, 
the sperm cells uptake more stain causing an increase in green fluorescent 
  
 
42 
intensity along the x-axis.  Another explaination could be that over-loading the 
sperm with stain could cause an uneven staining pattern seen on the scatterplot, 
thus a more elongated non-viable population at higher volumes as compared to 
a more rounded non-viable population at lesser volumes.  
The results of Experiments 1, 2 and 3 supported the use of a lower 
volume/concentration of the SYBR-14 working solution (0.5 µL/0.02µM) in 2.5 
mL of semen than previously recommended by the manufacturer (2.5 µL/0.1 
µM).  In addition, it was also determined that DMSO concentration alone would 
not affect recorded sperm membrane viability when used within the 
recommended volumes.  Therefore the remaining experiments utilized a SYBR-
14 working solution volume of 0.5 µL in 2.5 mL of semen. 
3.4. Experiment 4:  Effect of freezing and thawing on the SYBR-14 working 
solution   
 The LIVE/DEAD® Sperm Viability Kit gives two different methods for 
preparing the SYBR-14 working solution.  One method utilizes Garner’s solution 
as a buffer reagent and the second utilizes DMSO as a buffer reagent.  When 
using the method containing Garner’s solution, the SYBR-14 working solution 
must be prepared fresh for each experiment, whereas the manufacturer claims 
that the SYBR-14 working solution that contains DMSO as a buffer reagent can 
be frozen/thawed after preparation and re-used for later experiments.  To test 
whether the SYBR-14 working solution could be frozen/thawed and how many 
times the solution could be re-used without having an effect on the results of 
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sperm viability obtained from the flow cytometer, an experiment was conducted 
using one ejaculate from each of three stallions.  Prior to semen collection using 
the method described previously, a 10X dilution of SYBR-14 in DMSO, yielding a 
working concentration of 100 µM, was prepared in a single 0.5 mL Eppendorf 
tube to a total volume of 15 µL.  Three other 0.5 mL Eppendorf tubes were 
labeled according to the number of times the sample would be frozen/thawed 
(1X, 3X, or 6X).  Small aliquots (3.75 µL) were pipetted from the tube containing 
the SYBR-14 working solution and placed in each of the three tubes.  The 
original tube was labeled with “no F/T” (not frozen and thawed) and served as 
the control for Experiment 4.  A styrofoam container was filled with dry ice and 
the three tubes (1X, 3X, 6X) were placed in the container to allow the samples to 
freeze.  After a period of approximately 5 minutes, all tubes were removed and 
allowed to thaw to room temperature.  Tubes labeled with 3X and 6X were 
placed back in the dry ice and allowed to freeze again.  The tubes were 
removed, thawed, then re-frozen according to their treatment then stored out of 
direct light at room temperature until ready for use.   
 After semen collection, the neat semen was extended in INRA 96 to a 
concentration of approximately 25 x 106 sperm/mL and a volume of 50 mL then 
placed in a 50 mL conical tube.  Four flow cytometer tubes were prepared, one 
with each freeze/thaw treatment using the protocol previously described (0.5 µl 
SYBR-14/ 0.02µM), for each of three replicates performed on the same 
ejaculate. 
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3.4.1.  Results: Experiment 4:  Effect of freezing and thawing on the SYBR-14 
working solution   
 There was no difference (P>0.05) in recorded sperm membrane viability 
among the four SYBR-14 working solution freeze/thaw treatments (Tables 12 
and 13). 
 
Table 12.  Effect of treatment (number of freeze-thaw cycles) within replicates on 
the mean percent of viable sperm using the flow cytometer (n=12 for each 
replicate). 
  
Replicate Treatment Mean  
1 Control 
1X 
3X 
6X 
87.3a 
87.0a 
87.6a 
88.7a 
2 Control 
1X 
3X 
6X 
88.2a 
88.6a 
88.9a 
88.6a 
3 Control 
1X 
3X 
6X 
88.0a 
88.0a 
88.4a 
88.5a 
 § Percentage data (% viable) were arc sine-root transformed prior to statistical analysis.  
Original means and standard deviations are presented in the table but statistical tests 
were conducted on transformed data. 
a  Within replicate and treatment, means with different superscripts differ (P<0.05) 
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Table 13.  Effect of treatment (number of freeze-thaw cycles) on the mean 
percent sperm viability using the flow cytometer (N=36). 
 
Treatment Mean % viable 
Control 87.8a 
1X 87.9a 
3X 88.3a 
6X 88.6a 
 § Percentage data (% viable) were arc sine-root transformed prior to statistical analysis.  
Original means and standard deviations are presented in the table but statistical tests 
were conducted on transformed data. 
a  Within treatment, means with different superscripts differ (P<0.05) 
 
 
3.4.2.  Discussion: Experiment 4:  Effect of freezing and thawing on the SYBR-
14 working solution   
 There was no effect of freezing and thawing on the stability of the SYBR-
14 working solution.  Despite these findings the decision was made to prepare a 
large volume of the working solution and aliquot out smaller, separate volumes 
from this common tube to ensure that the SYBR-14 working solution used for the 
main experiment, Experiment 6, would come from the same dilution batch and 
for each ejaculate and time period, the SYBR-14 working solution would have 
been frozen/thawed the same number of times (1X).    
3.5.  Experiment 5:  Effect of storage temperature, time, and seminal plasma 
level on sperm membrane viability.   
 Experiment 5 was performed to compare the changes in sperm viability at 
two storage temperatures (23°C and 8°C), two time intervals (26 and 50 hours), 
and varying seminal plasma percentages (80%, 50%, 20%, 10%).  Based on 
previous data showing a detrimental effect of increasing percentages of seminal 
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plasma on motility [11, 27] the percentage of seminal plasma was varied in the 
different treatments in an attempt to produce varying populations of viable and 
non-viable sperm.  In addition, sperm storage for different times and at different 
temperatures was also expected to yield varying proportions of viable and non-
viable sperm.  This method was felt to be more physiological than was the 
method used in previous studies in which known concentrations of killed sperm 
were added [2, 13].   
A single ejaculate from one stallion was used for this experiment, and 
semen was collected as previously described.  Eight 5-mL cryovial tubes (four 
per storage temperature) were labeled with treatment group and prepared using 
neat semen and INRA 96 in different proportions to obtain different percentages 
of seminal plasma in the final preparation to a total volume of 5 mL.  The 
treatments were:  1) 80% - 1 mL INRA 96 / 4 mL neat semen; 2) 50% - 2.5 mL 
INRA 96 / 2.5 mL neat semen; 3) 20% - 4 mL INRA 96 / 1 mL neat semen; 4) 
10% - 4.5 mL INRA 96 / 0.5 mL neat semen (Table 14).  Samples were not 
diluted based on sperm concentration, therefore sperm concentration varied 
within and between treatment groups.  Room temperature samples were 
wrapped in a towel and stored out of direct light.  Cooled-stored samples (8°C) 
were stored in an Equitainer® I.  All samples were analyzed 26 and 50 hours 
after semen collection using the CASMA as described previously.  In addition, 
eosin-nigrosin slides were made of each sample at these times. 
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Table 14.  Treatments and volumes of semen and extender for each treatment 
for Experiment 5.  
 
Tube Label Volume (mL) semen Volume (mL) extender 
10 0.5 4.5 
20 4 1 
50 2.5 2.5 
80 1 4 
 
 
3.5.1.  Results: Experiment 5:  Effect of storage temperature, time, and seminal 
plasma level on sperm membrane viability   
There were no differences (P>0.05) found among temperature (8°C 
versus 23°C), and no interactions (P>0.05) were found between seminal plasma 
content and time, seminal plasma content and temperature, and time and 
temperature when sperm motion characteristics (TMOT and PMOT) were 
analyzed using the CASMA.  Significant differences (P<0.05) were found among 
seminal plasma content and time when sperm motion characteristics were 
analyzed with the CASMA and when sperm viability was assessed using eosin-
nigrosin.  Total and progressive motililty decreased significantly (P<0.05) with 
increasing proportions of seminal plasma (50% or greater).  Semen stored for 26 
hours maintained better motion characteristics than semen stored for 50 hours 
when all treatments were considered.  There was a significant difference 
(P<0.05) when sperm viability was analyzed with eosin-nigrosin stain among 
temperature as well.  Treatments stored at room temperature had slightly lower 
(85% for room temperature, 90% for cooled; P<0.05) viable populations as 
  
 
48 
compared to treatments in cooled-storage.  Table 15 shows the effect of 
treatment (seminal plasma content) on the means ± standard deviations (SD) for 
sperm motion characteristics (TMOT and PMOT) using the CASMA and for 
sperm viability (% viable) using eosin-nigrosin stain.  Tables 16 and 17 show the 
effects of time (26 hours versus 50 hours post-collection) and temperature (8°C 
versus 23°C), respectively, on the means ± standard deviations (SD) for sperm 
motion characteristics (TMOT and PMOT) using the CASMA and for sperm 
viability (% viable) using eosin-nigrosin stain. 
 
Table 15.  Effect of treatment (seminal plasma content) on sperm motility 
characteristics (TMOT and PMOT) and sperm membrane viability (%) using 
eosin-nigrosin (n=4 per treatment). 
 
Endpoint * Treatment ¥ Mean ± SD 
TMOT 10 
20 
50 
80 
90.5a±3.5 
88.8a±4.0 
44.3b±26.7 
16.0c±12.0 
PMOT 10 
20 
50 
80 
62.0a±12.6 
53.3a±12.6 
13.0b±13.7 
1.50c±1.3 
EN 10 
20 
50 
80 
94.0a±3.4 
93.3a±2.7 
90.8a±3.2 
72.4b±18.0 
* MOT = total spermatozoal motility (%); PMOT = progressive sperm motility (%);  
EN = sperm viability (%) as assessed using eosin-nigrosin stain.  
¥ 10 = 10% of total volume designated as seminal plasma; 20 = 20% of total 
volume designated as seminal plasma; 50 = 50% of total volume designated as 
seminal plasma; 80% of total volume designated as seminal plasma. 
§ Percentage data (TMOT, PMOT, EN) were arc sine-root transformed prior to 
statistical analysis.  Original means and standard deviations are presented in the 
table but statistical tests were conducted on transformed data. 
a, b, c Within treatment and endpoint, means with different superscripts differ (P<0.05) 
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 Treatments containing 10% and 20% seminal plasma had similar 
(P>0.05) sperm motion characteristics and sperm membrane viability.  
Treatments containing 10%, 20%, and 50% seminal plasma had similar 
(P>0.05) populations of viable sperm (%).  The treatment containing 80% 
seminal plasma was significantly different (P<0.05) from all other treatment 
groups when sperm motion characteristics and sperm viability was assessed.  
Samples analyzed 26 hours post-collection had significantly higher (P<0.05) 
sperm motion characteristics and % viable sperm when compared to these 
same treatment groups analyzed 50 hours post-collection (Table 16).  Treatment 
groups analyzed after storage in an Equitainer® I for 26 hours and 50 hours 
post-collection showed similar (P>0.05) sperm motion characteristics (TMOT 
and PMOT) when compared to treatment groups stored at room temperature 
(Table 17).  As assessed using eosin-nigrosin staining, treatment samples 
stored at room temperature had higher populations of viable sperm (P<0.05) 
when compared to those stored in an Equitainer® I. 
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Table 16.  Effect of time (26 hours versus 50 hours post-collection) on sperm 
motility characteristics (TMOT and PMOT) and sperm membrane viability (%) 
using eosin-nigrosin (n=8 replicates per treatment). 
 
Endpoint * Time ¥ Mean 
TMOT 26 
50 
68.6a 
51.1b 
PMOT 26 
50 
37.8a 
27.1b 
EN 26 
50 
91.9a 
83.3b 
* MOT = total spermatozoal motility (%); PMOT = progressive sperm motility (%);  EN = 
sperm viability (%) as assessed using eosin-nigrosin stain.  
¥ 26 = sperm analyzed 26 hours post-collection; 50 = sperm analyzed 50 hours post-
collection 
§ Percentage data (TMOT, PMOT, EN) were arc sine-root transformed prior to statistical 
analysis.  Original means are presented in the table but statistical tests were conducted 
on transformed data. 
a, b,  Within time and within endpoint, means with different superscripts differ (P<0.05) 
 
 
 
Table 17.  Effect of temperature (room versus cool) on sperm motility 
characteristics (TMOT and PMOT) and sperm membrane viability (%) using 
eosin-nigrosin (n=8 replicates per treatment). 
 
Endpoint * Temperature ¥ Mean ± SD 
TMOT room 
cool 
59.0a±33.4 
60.8a±39.0 
PMOT room 
cool 
35.9a±33.2 
29.0a±24.4 
EN room 
cool 
85.2a±16.8 
90.1b±5.7 
* MOT = total spermatozoal motility (%); PMOT = progressive sperm motility (%);  EN = 
sperm viability (%) as assessed using eosin-nigrosin stain.  
¥ room = sperm stored in room temperature; cool = sperm stored in an Equitainer®. 
§ Percentage data (TMOT, PMOT, EN) were arc sine-root transformed prior to statistical 
analysis.  Original means and standard deviations are presented in the table but 
statistical tests were conducted on transformed data. 
a, b,  Within temperature and within endpoint, means with different superscripts differ (P<0.05) 
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3.5.2.  Discussion: Experiment 5:  Effect of storage temperature, time, and 
seminal plasma level on sperm membrane viability   
 Increasing levels of seminal plasma have been reported to decrease 
sperm motility [5, 6, 8, 27, 28].  This was only true if the extender used to dilute 
the neat semen did not contain a modified Tyrode’s medium [11, 29-31], 
because the presence of any seminal plasma in an extender with Tyrode’s 
causes a decrease in sperm motility.  Similar to previous studies  [7-12], 20% 
seminal plasma supported higher motility than did higher concentrations. In 
addition, as storage time increased, the sperm motion characteristics and viable 
populations of sperm decreased.  These results indicated that findings with 10% 
seminal plasma were similar to 20% seminal plasma.  No significant differences 
(P<0.05) were found when the treatment containing 10% seminal plasma was 
compared to the treatment containing 20% seminal plasma when sperm 
membrane viability (eosin-nigrosin) and sperm motion characteristics (TMOT 
and PMOT) were assessed, thus is was decided to utilize 20% seminal plasma 
as the base percentage.  Although room temperature (23°C) samples had a 
slightly lower viable population compared to cooled storage (8°C) storage 
(85.15% compared to 90.1%) when sperm membrane viability (eosin-nigrosin) 
was assessed, it was decided to utilize cooled-storage only for the main 
experiment (Experiment 6) comparing flow cytometery, the NucleoCounter® SP-
100TM , and eosin-nigrosin staining as methods for assessment of sperm 
membrane viability.  
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3.6.  Experiment 6:  Comparison of methods for detecting sperm membrane 
viability and seminal plasma effects on sperm motion characteristics and 
membrane viability        
Three gel-free ejaculates were collected from each of three stallions 
(N=9) using the protocol previously described.  The semen was divided into 
three 15-mL polypropylene conical tubes (Becton Dickinson Labware, Franklin 
Lakes, NJ, USA) that had been previously prepared and placed in an incubator 
set at 37°C with varying volumes of a milk-based semen extender, INRA 96 
(IMV Technologies, L’Aigle, France) with 1 mg/mL added timentin 
(GlaxoSmithKline, Research Traingle Park, NC, USA).  This extender/antibiotic 
solution was referred to as INRA-T.  Semen was placed in a fourth conical tube 
containing a mixture of INRA-T and frozen/thawed seminal plasma obtained 
from a previous ejaculate collected from the same stallion.  Volumes of neat 
semen, frozen/thawed seminal plasma, and INRA-T were adjusted within a total 
tube volume of 12 mL to give the following treatments, 1) 80SP- 80% neat 
semen / 20% INRA-T (thus 80% seminal plasma); 2) 80SP/20 - 20% neat 
semen, 60% of the stallion’s own frozen/thawed seminal plasma, and 20% 
INRA-T (thus 80% seminal plasma, but with 25% the sperm concentration of 
Treatment 80SP; 3) 50SP- 50% neat semen and 50% INRA-T (50% seminal 
plasma and 62.5% (⅝) the concentration of sperm as in 80SP); 4) 20SP -20% 
neat semen and 80% INRA-T (20% seminal plasma and 25% the concentration 
of sperm as in 80SP).  
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The extended semen was mixed thoroughly.  In each treatment, four mL 
of extended semen was placed into each of three capped polypropylene tubes 
(Cryogenic vials [4.0 mL]; Corning Life Sciences, Lowell, MA, USA) previously 
labeled with treatment (80SP, 80SP/20, 50SP, 20SP) and time (T0, T24, T48).  
Treatment T0 was placed in a drawer for immediate analysis.  Treatment T24 
was placed in a commercial semen-transport container (Equitainer® I; Hamilton 
Research, Inc., South Hamilton, MA, USA) for cooled-storage at 8°C and 
analysis 24 hours post-collection.  Treatment T48 was placed in a separate 
Equitainer® I for cooled-storage at 8°C and analysis 48 hours post-collection.   
Immediately prior to analysis using the methods described below, the tubes 
containing the treatments to be analyzed were incubated for 10 minutes at 37°C.   
Each treatment was incubated separately before analysis, and the remaining 
tubes for that time period remained in storage.  For each analysis method and 
time interval the treatments were run in the following order:  80SP, 80SP/20, 
50SP, 20SP.  Three replicates (three samples from each treatment tube) were 
performed on each of the four treatments using the flow cytometer, 
NucleoCounter® SP-100TM and eosin-nigrosin for assessment of sperm 
membrane viability, and the CASMA for assessment of sperm motion 
characteristics using the protocols previously described in materials and 
methods. The SYBR-14 working solution used was 0.5 µL SYBR / 0.02 µM that 
had been previously diluted 10-fold in DMSO and frozen then thawed one time 
and added to 2.5 mL of semen.   
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3.6.1.  Results: Experiment 6:  Comparison of methods for detecting sperm 
membrane viability and seminal plasma effects on sperm motion characteristics 
and membrane viability        
 There was an effect (P<0.05) of time, stallion, ejaculate within stallion, 
and treatment on the mean percent of viable sperm for the flow cytometer, 
NucleoCounter® SP-100TM, and eosin-nigrosin staining (N=324).  There was an 
interaction of treatment and time on the mean percent of viable sperm for the 
flow cytometer, NucleoCounter® SP-100TM, and eosin-nigrosin staining 
(P<0.05).  Treatment 20SP (20% neat semen and 80% INRA-T; 20% seminal 
plasma and ¼ the concentration of sperm as in 80SP) and 50SP (50% neat 
semen and 50% INRA-T; 50% seminal plasma and ⅝ the concentration of 
sperm as in 80SP) yielding significantly higher values (P<0.05) for sperm 
membrane viability [all three methods of assessing sperm membrane viability 
(FC, NC, EN)] when compared to the other treatments within all times (0, 24, 48 
hours) (Table 17).  Treatment 80SP/20 (20% neat semen, 60% of the stallion’s 
own frozen/thawed seminal plasma, and 20% INRA-T; thus 80% seminal 
plasma, but with ¼ the sperm concentration of Treatment 80SP) was inferior to 
all other treatment groups for sperm motion characteristics and membrane 
viability (Table 18).  Total and progressive sperm motility decreased significantly 
as the concentration (%V/V) of seminal plasma increased (P<0.05) with 
80SP/20 having the lowest total and progressive sperm motility. 
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At Time 0, although some treatments were statistically different (P<0.05), 
from a clinical approach all treatments were similar, with no more than a 7.5% 
difference for sperm motion characteristics and a 4.2% difference for sperm 
viability (Table 19, Figure 6).  At Time 24 (Table 20, Figure 7), sperm motion 
characteristics (TMOT and PMOT) decreased significantly (P<0.05) as the 
concentration (%V/V) of seminal plasma increased with 80SP/20 being inferior 
to all other treatments (P<0.05).  Treatments 20SP and 50SP were similar to 
each other (P>0.05) but superior to other treatments when sperm viability was 
assessed using the flow cytometer, the NucleoCounter® SP-100TM, and eosin-
nigrosin staining (P<0.05).  Treatments 80SP and 80SP/20 were not significantly 
different (P>0.05) when viability was assessed using eosin-nigrosin, however, 
when analyzed using the flow cytometer and NucleoCounter® SP-100TM, 
Treatment 80SP/20 was inferior to 80SP (P<0.05).  At Time 48 (Table 21, Figure 
8), Treatments 20SP and 50SP were not significantly different (P>0.05) when 
sperm membrane viability was assessed using the three methods (flow 
cytometer, NucleoCounter® SP-100™, eosin-nigrosin).  Sperm motion 
characteristics decreased significantly (P<0.05) among Treatments 20SP, 50SP 
and 80SP, with 80SP being inferior to the treatments containing less seminal 
plasma (20SP and 50SP), but not significantly different (P>0.05) from 80SP/20. 
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Table 18.  The effect of treatment on the mean values (mean ± SD) of sperm 
motility (TMOT & PMOT) and sperm membrane viability as measured by flow 
cytometry (FC), eosin-nigrosin staining (E-N), and the NucleoCounter® SP-
100TM(NC) within T0, T24, and T48 combined (n=81 for each treatment at each 
endpoint).  
 
Endpoint* 20SP† 50SP† 80SP† 80SP/20† 
Conc 23.8-108.2 59.2-266.7 88.9-404.0 13.1-105.8 
FC 84.1a±11.4 83.8a±11.5 58.5b±24.8 52.6c±26.5 
TMOT 81.1a±7.0 67.5b±22.6 47.3c±33.1 38.8d±35.5 
PMOT 43.4a±14.9 30.9b±21.8 22.7c±26.1 18.1d±25.3 
NC 79.3a±12.1 77.7a±12.9 51.2b±27.4 46.5c±28.4 
E-N 82.6a±10.5 81.2a±12.0 64.7b±22.9 58.3c±23.7 
* Conc = range of sperm concentration (x 106) for each treatment;  FC = viable 
sperm assessed using the flow cytometer (%); TMOT = total sperm motility (%); 
PMOT = progressive sperm motility (%);  NC = viable sperm assessed using the 
NucleoCounter® SP-100TM; EN = viable spern assessed using eosin-nigrosin 
staining (%).  
† 20SP = contained 20% neat semen and 80% extender; 50SP = contained 50% 
neat semen and 50% extender; 80SP = contained 80% neat semen and 20 
extender; 80SP/20 = contained 20% neat semen, 60% stallion’s own seminal 
plasma, and 20% extender. 
§ Percentage data (FC, TMOT, PMOT, NC, EN) were arc sine-root transformed 
prior to statistical analysis.  Original means and standard deviations are 
presented in the table but statistical tests were conducted on transformed data. 
a, b, c, d Within treatments and endpoint, means with different superscripts across rows 
differ (P<0.05) 
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Table 19. The effect of treatment at Time 0 on the mean values (mean ± SD) of 
sperm motility (TMOT & PMOT) and sperm membrane viability as measured by 
flow cytometry (FC), eosin-nigrosin staining (E-N), and the NucleoCounter® SP-
100TM(NC) (n=27).  
 
Endpoint* Time£ 20SP† 50SP† 80SP† 80SP/20† 
Conc 0 23.8-108.2 59.2-266.7 88.9-404.0 13.1-105.8 
FC 0 84.04a±11 85.63a±11 84.52a±12 82.00b±12 
TMOT 0 83.04b±6 85.59a±6 85.74a±6 84.78a±8 
PMOT 0 55.78a±15 54.82a±16 56.48a±15 50.59b±17 
NC 0 80.26a±12 80.3a±13 79.89a±13 77.70b±15 
E-N 0 82.07b,a±14 81.93b,a±15 82.85a±14 79.59b±15 
* Conc = range of sperm concentration (x 106) for each treatment; FC = viable 
sperm assessed using the flow cytometer (%); TMOT = total sperm motility (%); 
PMOT = progressive sperm motility (%);  NC = viable sperm assessed using the 
NucleoCounter® SP-100TM; EN = viable spern assessed using eosin-nigrosin 
staining (%).  
£ Time 0 = Semen analyzed immediately post-collection. 
† 20SP = contained 20% neat semen and 80% extender; 50SP = contained 50% 
neat semen and 50% extender; 80SP = contained 80% neat semen and 20 
extender; 80SP/20 = contained 20% neat semen, 60% stallion’s own seminal 
plasma, and 20% extender. 
§ Percentage data (FC, TMOT, PMOT, NC, EN) were arc sine-root transformed 
prior to statistical analysis.  Original means and standard deviations are 
presented in the table but statistical tests were conducted on transformed data. 
a, b,  Within treatments, endpoint at Time 0 means with different superscripts across 
rows differ (P<0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
58 
 
 
Figure 6.  Comparison of findings among three different methods for assessment 
of sperm membrane viability (flow cytometer (FC), NucleoCounter SP-100 (NC), 
and eosin-nigrosin (EN)) and sperm motion characteristics (TMOT and PMOT) 
according to treatment (percentage of seminal plasma) at Time 0. 
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Table 20. The effect of treatment at Time 24 on the mean values (mean ± SD) of 
sperm motility (TMOT & PMOT) and sperm membrane viability as measured by 
flow cytometry (FC), eosin-nigrosin staining (E-N), and the NucleoCounter® SP-
100TM(NC) (N=27). 
 
Endpoint* Time£ 20SP† 50SP† 80SP† 80SP/20† 
Conc 24 23.8-108.2 59.2-266.7 88.9-404.0 13.1-105.8 
FC 24 83.33a±12 83.26a±12 58.70b±14 53.96c±9 
TMOT 24 84.22a ±6 76.93b±7 48.85c±10 26.11d±16 
PMOT 24 42.04a±10 29.26b±8 11.00c±4 3.44d±4 
NC 24 79.70a±13 77.37a±13 51.63b±15 44.56c±17 
E-N 24 82.74a±13 80.63a±16 65.37b±19 60.96b±16 
* Conc = range of sperm concentration (x 106) for each treatment; FC = viable 
sperm assessed using the flow cytometer (%); TMOT = total sperm motility (%); 
PMOT = progressive sperm motility (%);  NC = viable sperm assessed using the 
NucleoCounter® SP-100TM; EN = viable spern assessed using eosin-nigrosin 
staining (%).  
£ Time 24 = Semen analyzed after 24 hours of cooled-storage in and Equitainer®. 
† 20SP = contained 20% neat semen and 80% extender; 50SP = contained 50% 
neat semen and 50% extender; 80SP = contained 80% neat semen and 20 
extender; 80SP/20 = contained 20% neat semen, 60% stallion’s own seminal 
plasma, and 20% extender. 
§ Percentage data (FC, TMOT, PMOT, NC, EN) were arc sine-root transformed 
prior to statistical analysis.  Original means and standard deviations are 
presented in the table but statistical tests were conducted on transformed data. 
a, b, c, d Within treatments and endpoint at Time 24 means with different superscripts 
across rows differ (P<0.05) 
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Figure 7.  Comparison of findings among three different methods for assessment 
of sperm membrane viability (flow cytometer (FC), NucleoCounter SP-100 (NC), 
and eosin-nigrosin (EN)) and sperm motion characteristics (TMOT and PMOT) 
according to treatment (percentage of seminal plasma) after 24 hours of cooled-
storage. 
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Table 21. The effect of treatment at Time 48 on the mean values (mean ± SD) of 
sperm motility (TMOT & PMOT) and sperm membrane viability as measured by 
flow cytometry (FC), eosin-nigrosin staining (E-N), and the NucleoCounter® SP-
100TM (NC) (N=27).  
 
Endpoint* Time£ 20SP† 50SP† 80SP† 80SP/20† 
Conc 48 23.8-108.2 59.2-266.7 88.9-404.0 13.1-105.8 
FC 48 84.82a±11 82.41a±11 32.15b±11 21.70c±7 
TMOT 48 76.04a±7 40.00b±17 7.22c±6 5.59c±7 
PMOT 48 32.26a±9 8.63b±5 0.63c±1 0.15c±0.4 
NC 48 77.96a±12 75.48a±13 22.00b±13 17.26b±8 
E-N 48 82.93a±12 80.93a±13 45.85b±19 34.26c±13 
* Conc = range of sperm concentration (x 106) for each treatment; FC = viable 
sperm assessed using the flow cytometer (%); TMOT = total sperm motility (%); 
PMOT = progressive sperm motility (%);  NC = viable sperm assessed using the 
NucleoCounter® SP-100TM; EN = viable spern assessed using eosin-nigrosin 
staining (%).  
£ Time 48 = Semen analyzed after 48 hours of cooled-storage in and Equitainer®. 
† 20SP = contained 20% neat semen and 80% extender; 50SP = contained 50% 
neat semen and 50% extender; 80SP = contained 80% neat semen and 20 
extender; 80SP/20 = contained 20% neat semen, 60% stallion’s own seminal 
plasma, and 20% extender. 
§ Percentage data (FC, TMOT, PMOT, NC, EN) were arc sine-root transformed 
prior to statistical analysis.  Original means and standard deviations are 
presented in the table but statistical tests were conducted on transformed data. 
a, b, c Within treatments and endpoint at Time 48 means with different superscripts 
across rows differ (P<0.05) 
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Figure 8.  Comparison of findings among three different methods for assessment 
of sperm membrane viability (flow cytometer (FC), NucleoCounter SP-100 (NC), 
and eosin-nigrosin (EN)) and sperm motion characteristics (TMOT and PMOT) 
according to treatment (percentage of seminal plasma) after 48 hours of cooled-
storage. 
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The coefficients of variation for the transformed data for the flow 
cytometer, NucleoCounter® SP-100TM, eosin-nigrosin staining, and total motility 
were all below 7% (Table 22), with the progressive motility (PMOT) being the 
least repeatable (6.07%) and the flow cytometer being the most repeatable 
(1.42%).   
 
 
Table 22.  Within - sample repeatability (coefficients of variation) for the three 
methods for determining sperm membrane viability (FC, NC, E-N) and total and 
progressive sperm motility (TMOT, PMOT). 
 
Endpoint* Coefficient of 
Variation (%) 
FC 1.42 
TMOT 5.56 
PMOT 6.07 
NC 4.89 
E-N 4.98 
* FC = viable sperm assessed using the flow cytometer (%); TMOT = total sperm 
motility (%); PMOT = progressive sperm motility; NC = viable sperm assessed 
using the NucleoCounter® SP-100TM; E-N = viable spern assessed using eosin-
nigrosin staining (%).  
§ Percentage data (FC, TMOT, NC, EN) were arc sine-root transformed prior to 
statistical analysis.  0.0125 was substituted for all values of zero.  Coefficients of 
variation were analyzed on the transformed data. 
 
 
  
Bland and Altman plots were prepared to determine the agreement 
between the methods for detecting sperm viability (flow cytometry, 
NucleoCounter® SP-100TM, eosin-nigrosin staining) and for determining, if any, 
the agreement between total motility using CASMA and sperm viability using the 
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flow cytometer, the NucleoCounter® SP-100TM, and eosin-nigrosin staining.  
These Bland and Altman plots as well as regression plots for each comparison 
were graphed at Times 0 (Figures 9-20), 24 (Figures 21-32), and 48 (Figures 33-
44).  Tables 23-28 show the equations and associated values used for plotting 
the Bland and Altman plots, as well as the absolute values of the mean 
differences for each plot.   
At Time 0, the flow cytometer held a five percentage-point difference 
(absolute value) higher than the NucleoCounter® SP-100TM and eosin-nigrosin 
staining (Table 23 and 24).  When comparisons were made with the 
NucleoCounter® SP-100TM and eosin-nigrosin staining, the method agreement 
also averaged five percentage-points, however these data points fell above and 
below the mean difference (Table 25).  When total motility was compared to 
viability using the three methods at Time 0 the agreements remained between a 
six and eight percentage-point difference (Tables 26-28).  The R-values were 
high for all comparisons at Time 0 (Figures 10, 12, 14, 16, 18, and 20). 
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Figure 9.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and the NucleoCounter® SP-100TM to the 
mean of the flow cytomer and the NucleoCounter® SP-100TM at Time 0 (N=108). 
Dashed lines represent + or – 2 standard deviations (lower and upper limits of 
agreement); solid line represents mean difference. 
 
 
 
Table 23.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and the NucleoCounter® SP-100TM 
(NC) at Time 0. 
 
 
Value (equation) 
FC-NC absolute value 
(FC-NC) 
(FC+NC)/2 
sum 486.9 496.9 8833.5 
average 4.5 4.6 81.8 
standard deviation (SD) 4.7 4.6 12.1 
lower limit of agreement  
(average-(2*SD)) 
-4.8 -4.5 57.5 
upper limit of agreement 
(average+(2*SD)) 
13.8 13.7 106.1 
Range  -3 – 37 3 - 37 52 -94 
number of events 108.0 108.0 108.0 
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Figure 10.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and the NucleoCounter® SP-100TM at Time 0 (N=108).  Dashed 
line represents the line of equality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R=0.937 
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Figure 11.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and eosin-nigrosin staining to the mean of 
the flow cytomer and eosin-nigrosin staining at Time 0 (N = 108). Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 24.  Equations and their associated values used in preparing the Bland  
and Altman plots for the flow cytometer (FC) and eosin-nigrosin (EN) at Time 0. 
 
 
Value (equation) FC-EN 
absolute value 
(FC-EN) (FC+EN)/2 
sum 259.6 524.6 8947.1 
average 2.4 4.9 82.8 
standard deviation (SD) 7.1 5.7 12.4 
lower limit of agreement  
(average-(2*SD)) -11.8 -6.5 58.0 
upper limit of agreement 
(average+(2*SD)) 16.6 16.2 107.7 
Range  -15 - 32 15 - 32 52 - 94 
number of events 108.0 108.0 108.0 
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Figure 12.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and eosin-nigrosin staining at Time 0 (N=108).  Dashed line 
represents the line of equality. 
 
 
 
 
 
 
 
 
R=0.868 
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Figure 13.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the NucleoCounter® SP-100TM and eosin-nigrosin staining to 
the mean of the NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 
0 (N=108).  Dashed lines represent + or – 2 standard deviations (lower and 
upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 25.  Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM  (NC) and eosin-nigrosin 
(EN) at Time 0. 
 
 
Value (equation) NC-EN 
absolute value 
(NC-EN) (NC+EN)/2 
sum -227.3 470.7 8703.7 
average -2.1 4.4 80.6 
standard deviation (SD) 5.5 3.9 13.4 
lower limit of agreement  
(average-(2*SD)) -13.0 -3.4 53.8 
upper limit of agreement 
(average+(2*SD)) 8.8 12.1 107.4 
Range -26 – 11 11 – 26 52 - 95 
number of events 108.0 108.0 108.0 
 
  
 
70 
 
Figure 14.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 0 (N=108). 
Dashed line represents the line of equality. 
R=0.923 
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Figure 15.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and total motility with the CASMA to the 
mean of the flow cytometer and total motility at Time 0 (N=108).  Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 26.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and total sperm motility (TMOT) at 
Time 0. 
 
Value (equation) FC-TMOT 
absolute value 
(FC-TMOT) (FC+TMOT)/2 
sum -80.1 600.8 9117.0 
average -0.7 5.6 84.4 
standard deviation (SD) 7.3 4.8 8.6 
lower limit of agreement 
(average-(2*SD)) -15.4 -4.1 67.2 
upper limit of agreement 
(average+(2*SD)) 13.9 15.2 101.7 
Range -22 – 16 16 – 22 62 - 95 
number of events 108.0 108.0 108.0 
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Figure 16.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and total sperm motility with the CASMA at Time 0 (N=108).  
Dashed line represents the line of equality. 
R=0.809 
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Figure 17.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the NucleoCounter® SP-100TM and total motility with the 
CASMA to the mean of the NucleoCounter® SP-100TM and total motility at Time 
0 (N=108). Dashed lines represent + or – 2 standard deviations (lower and 
upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 27. Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM (NC) and total sperm 
motility (TMOT) at Time 0. 
 
 
Value (equation) NC-TMOT 
absolute value 
(NC-TMOT) (NC+TMOT)/2 
sum -567.0 775.0 8873.5 
average -5.3 7.2 82.2 
standard deviation (SD) 8.3 6.7 9.5 
lower limit of agreement  
(average-(2*SD)) -21.9 -6.3 63.2 
upper limit of agreement 
(average+(2*SD)) 11.4 20.6 101.2 
Range -23 – 9 9 – 23 58 - 93 
number of events 108.0 108.0 108.0 
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Figure 18.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and total sperm motility with the CASMA at Time 0 
(N=108).  Dashed line represents the line of equality. 
 
 
 
 
 
 
 
R=0.849 
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Figure 19.  Bland and Altman plot comparing the difference in sperm membrane 
viability with eosin-nigrosin staining and total sperm motility with the CASMA to 
the mean of eosin-nigrosin staining and total motility at Time 0 (N=108).  Dashed 
lines represent + or – 2 standard deviations (lower and upper limits of 
agreement); solid line represents mean difference. 
 
 
 
Table 28. Equations and their associated values used in preparing the Bland 
and Altman plots for eosin-nigrosin staining (EN) and total sperm motility 
(TMOT) at Time 0. 
 
Value (equation) EN-TMOT 
absolute value 
(EN-TMOT) (EN+TMOT)/2 
sum -339.7 853.7 8987.2 
average -3.1 7.9 83.2 
standard deviation (SD) 10.1 7.0 9.8 
lower limit of agreement  
(average-(2*SD)) -23.4 -6.1 63.6 
upper limit of agreement 
(average+(2*SD)) 17.1 21.9 102.8 
Range -27 – 14 14 – 27 62 - 96 
number of events 108.0 108.0 108.0 
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Figure 20.  Regression plot comparing the mean percent viable sperm for eosin-
nigrosin staining and total sperm motility with the CASMA at Time 0 (N=108).  
Dashed line represents the line of equality. 
 
 
 
 
 
 
 
 
 
 
 
R=0.762 
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At Time 24, the flow cytometer held a 6.5 percentage-point difference 
(absolute value) when compared to the NucleoCounter® SP-100TMand eosin-
nigrosin staining (Table 29 and 30).  Data points for the flow cytometer were 
above the mean difference when compared to the NucleoCounter® SP-100TM, 
however the data points fell above and below the mean difference for the flow 
cytometer and eosin-nigrosin staining.   When comparisons were made with the 
NucleoCounter® SP-100TM and eosin-nigrosin staining, the method agreement 
averaged an approximate 10 percentage-point, and these data points fell above 
and below the mean difference (Table 31).  When total motility was compared to 
viability using the three methods at Time 24 the agreements had an approximate 
10 percentage-point difference for the NucleoCounter® SP-100TM and the flow 
cytometer compared to total motility (Tables 32 and 33), and a 20 percentage-
point difference for eosin-nigrosin and total motility (Table 34).  The R-values 
remained high for all comparisons among methods for detecting viability (flow 
cytometer, NucleoCounter® SP-100TM, eosin-nigrosin) at Time 24 (Figures 22, 
24, 26).  The R-values decreased at Time 24 for the comparisons of the three 
methods with total motility (Figures 28, 30, 32). 
 
  
 
78 
 
Figure 21.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and the NucleoCounter® SP-100TM to the 
mean of the flow cytometer and the NucleoCounter® SP-100TM at Time 24 
(N=108).  Dashed lines represent + or – 2 standard deviations (lower and upper 
limits of agreement); solid line represents mean difference. 
 
 
 
Table 29.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and the NucleoCounter® SP-100TM 
(NC) at Time 24. 
 
 
Value (equation) 
FC-NC absolute value 
(FC-NC) 
(FC+NC)/2 
sum 701.4 706.9 7188.7 
average 6.5 6.5 66.6 
standard deviation (SD) 7.4 7.3 19.3 
lower limit of agreement  
(average-(2*SD)) -8.2 -8.1 28.0 
upper limit of agreement 
(average+(2*SD)) 21.2 21.2 105.2 
Range -1 – 52 1 – 52 26 - 93 
number of events 108.0 108.0 108.0 
 
  
 
79 
 
Figure 22.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and the NucleoCounter® SP-100TM at Time 24 (N=108).  Dashed 
line represents the line of equality.  
 
 
 
 
 
 
 
R=0.942 
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Figure 23.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and eosin-nigrosin staining to the mean of 
the flow cytomer and eosin-nigrosin staining at Time 24 (N=108).  Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 30.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and eosin-nigrosin staining (EN) at 
Time 24. 
 
 
Value (equation) FC-EN 
absolute value 
(FC-EN) (FC+EN)/2 
sum -284.6 649.4 7681.7 
average -2.6 6.0 71.1 
standard deviation (SD) 8.7 6.7 17.6 
lower limit of agreement  
(average-(2*SD)) -20.0 -7.5 36.0 
upper limit of agreement 
(average+(2*SD)) 14.7 19.5 106.3 
Range -21 – 46 21 – 46 31 - 96 
number of events 108.0 108.0 108.0 
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Figure 24.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and eosin-nigrosin staining at Time 24 (N=108).  Dashed line 
represents the line of equality. 
R=0.886 
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Figure 25.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the NucleoCounter® SP-100TMand eosin-nigrosin staining to 
the mean of the NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 
24 (N=108).  Dashed lines represent + or – 2 standard deviations (lower and 
upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 31.  Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM (NC) and eosin-nigrosin 
staining (EN) at Time 24. 
 
 
Value (equation) NC-EN 
absolute value 
(NC-EN) (NC+EN)/2 
sum -986.0 1145.3 7331.0 
average -9.1 10.6 67.9 
standard deviation (SD) 11.0 9.6 18.9 
lower limit of agreement  
(average-(2*SD)) -31.1 -8.5 30.0 
upper limit of agreement 
(average+(2*SD)) 12.9 29.7 105.8 
Range -53 – 40 40 – 53 25 - 93 
number of events 108.0 108.0 108.0 
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Figure 26.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 24 (N=108). 
Dashed line represents the line of equality. 
R=0.854 
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Figure 27.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and total motility with the CASMA to the 
mean of the flow cytometer and total motility at Time 24 (N=108).  Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 32.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and total sperm motility (TMOT) at 
Time 24. 
Value (equation) FC-TMOT 
absolute value 
(FC-TMOT) (FC+TMOT)/2 
sum 1164.4 1628.5 6957.2 
average 10.8 15.1 64.4 
standard deviation (SD) 18.2 14.8 20.1 
lower limit of agreement 
(average-(2*SD)) -25.6 -14.5 24.3 
upper limit of agreement 
(average+(2*SD)) 47.2 44.6 104.5 
Range -16 – 62 16 – 62 27 - 94 
number of events 108.0 108.0 108.0 
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Figure 28.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and total sperm motility with the CASMA at Time 24 (N=108).  
Dashed line represents the line of equality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R=0.699 
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Figure 29.  Bland and Altman plot comparing the difference in sperm membrane 
viability with the NucleoCounter® SP-100TM and total sperm motility with the 
CASMA to the mean of the NucleoCounter® SP-100TM and total sperm motility 
at Time 24 (N=108).  Dashed lines represent + or – 2 standard deviations (lower 
and upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 33. Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM (NC) and total sperm 
motility (TMOT) at Time 24. 
 
 
Value (equation) NC-TMOT 
absolute value 
(NC-TMOT) (NC+TMOT)/2 
sum 463.0 1643.0 6606.5 
average 4.3 15.2 61.2 
standard deviation (SD) 20.7 14.7 21.0 
lower limit of agreement  
(average-(2*SD)) -37.2 -14.1 19.2 
upper limit of agreement 
(average+(2*SD)) 45.8 44.6 103.1 
Range -53 – 59 53 – 59 26 - 93 
number of events 108.0 108.0 108.0 
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Figure 30.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and total sperm motility with the CASMA at Time 24 
(N=108). Dashed line represents the line of equality. 
R=0.617 
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Figure 31.  Bland and Altman plot comparing the difference in sperm membrane 
viability with eosin-nigrosin staining and total sperm motility with the CASMA to 
the mean of eosin-nigrosin staining and total sperm motility at Time 24 (N=108).  
Dashed lines represent + or – 2 standard deviations (lower and upper limits of 
agreement); solid line represents mean difference. 
 
 
 
Table 34. Equations and their associated values used in preparing the Bland 
and Altman plots for eosin-nigrosin staining (EN) and total sperm motility 
(TMOT) at Time 24. 
 
 
Value (equation) EN-TMOT 
absolute value 
(EN-TMOT) (EN+TMOT)/2 
sum 1449.0 2072.3 7099.5 
average 13.4 19.2 65.7 
standard deviation (SD) 24.1 19.8 18.5 
lower limit of agreement  
(average-(2*SD)) -34.8 -20.4 28.7 
upper limit of agreement 
(average+(2*SD)) 61.6 58.8 102.8 
Range -41 – 80 41 – 80 26 - 94 
number of events 108.0 108.0 108.0 
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Figure 32.  Regression plot comparing the mean percent viable sperm with 
eosin-nigrosin staining and total sperm motility with the CASMA at Time 24 
(N=108). Dashed line represents the line of equality. 
 
 
 
 
 
 
 
 
R=0.428 
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At Time 48, the flow cytometer held a 7.9 percentage-point difference 
(absolute value) when compared to the NucleoCounter® SP-100TM and an 8.5 
percentage-point difference when compared to eosin-nigrosin staining (Tables 
35 and 36).  Values for viability using the flow cytometer were higher than those 
values found when the NucleoCounter® SP-100TM was used.  Data points fell 
above and below the mean difference when comparisons were made with the 
flow cytometer and eosin-nigrosin staining, and with the NucleoCounter® SP-
100TM and eosin-nigrosin staining.  When comparisons were made with the 
NucleoCounter® SP-100TM and eosin-nigrosin staining, the method agreement 
averaged an approximate 13 percentage-point difference, and these data points 
fell above and below the mean difference (Table 37).  When total motility was 
compared to viability using the three methods at Time 48 the agreements had an 
approximate 20 percentage-point difference for the NucleoCounter® SP-100TM 
and the flow cytometer compared to total motility (Tables 38 and 39), and a 30 
percentage-point difference for eosin-nigrosin and total motility (Table 40).  The 
R-values remained high for all comparisons among methods for detecting 
viability (flow cytometer, NucleoCounter® SP-100TM, eosin-nigrosin) at Time 48 
(Figures 34, 36, 38).  The R-values decreased at Time 48 as compared to Time 
0 however these values were higher for Time 48 when compared to Time 24 for 
the comparisons of the three methods with total motility (Figures 40, 42, 44). 
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Figure 33.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and the NucleoCounter® SP-100TM to the 
mean of the flow cytometer and the NucleoCounter® SP-100TM at Time 48 
(N=108).  Dashed lines represent + or – 2 standard deviations (lower and upper 
limits of agreement); solid line represents mean difference. 
 
 
 
Table 35.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and the NucleoCounter® SP-100TM 
(NC) at Time 48. 
 
 
Value (equation) 
 
FC-NC 
absolute value 
(FC-NC) 
 
(FC+NC)/2 
sum 764.4 858.2 5585.2 
average 7.1 7.9 51.7 
standard deviation (SD) 6.2 5.0 30.6 
lower limit of agreement  
(average-(2*SD)) -5.4 -2.1 -9.5 
upper limit of agreement 
(average+(2*SD)) 19.5 18.0 112.9 
Range -10 – 23 10 – 23 7 - 94 
number of events 108.0 108.0 108.0 
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Figure 34.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and the NucleoCounter® SP-100TM at Time 48 (N=108).  Dashed 
line represents the line of equality.  
 
 
 
 
 
 
 
R=0.980 
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Figure 35.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and eosin-nigrosin staining to the mean of 
the flow cytomer and eosin-nigrosin staining at Time 48 (N=108).  Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 36.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and eosin-nigrosin staining (EN) at 
Time 48. 
 
 
Value (equation) FC-EN 
absolute value 
(FC-EN) (FC+EN)/2 
sum -621.6 922.3 6278.2 
average -5.8 8.5 58.1 
standard deviation (SD) 13.2 11.5 27.5 
lower limit of agreement  
(average-(2*SD)) -32.1 -14.5 3.0 
upper limit of agreement 
(average+(2*SD)) 20.6 31.6 113.2 
Range -42 – 13 13 – 42 12 - 96 
number of events 108.0 108.0 108.0 
 
  
 
94 
 
Figure 36.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and eosin-nigrosin staining at Time 48 (N=108).  Dashed line 
represents the line of equality. 
R=0.904 
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Figure 37.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the NucleoCounter® SP-100TM and eosin-nigrosin staining to 
the mean of the NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 
48 (N=108).  Dashed lines represent + or – 2 standard deviations (lower and 
upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 37.  Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM (NC) and eosin-nigrosin 
staining (EN) at Time 48. 
 
 
Value (equation) NC-EN 
absolute value 
(NC-EN) (NC+EN)/2 
sum -1386.0 1422.0 5896.0 
average -12.8 13.2 54.6 
standard deviation (SD) 12.7 12.3 27.8 
lower limit of agreement  
(average-(2*SD)) -38.2 -11.5 -1.1 
upper limit of agreement 
(average+(2*SD)) 12.5 37.8 110.3 
Range -51 – 7 7 – 51 5 - 94 
number of events 108.0 108.0 108.0 
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Figure 38.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and eosin-nigrosin staining at Time 48 (N=108). 
Dashed line represents the line of equality. 
R=0.916 
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Figure 39.  Bland and Altman plot comparing the difference in sperm membrane 
viability between the flow cytometer and total motility with the CASMA to the 
mean of the flow cytometer and total motility at Time 48 (N=108).  Dashed lines 
represent + or – 2 standard deviations (lower and upper limits of agreement); 
solid line represents mean difference. 
 
 
 
Table 38.  Equations and their associated values used in preparing the Bland 
and Altman plots for the flow cytometer (FC) and total sperm motility (TMOT) at 
Time 24. 
 
Value (equation) FC-TMOT 
absolute value 
(FC-TMOT) (FC+TMOT)/2 
sum 2488.4 2575.8 4723.2 
average 23.0 23.8 43.7 
standard deviation (SD) 20.0 19.0 28.9 
lower limit of agreement 
(average-(2*SD)) -16.9 -14.1 -14.0 
upper limit of agreement 
(average+(2*SD)) 63.0 61.8 101.5 
Range -10 – 81 10 – 81 6 - 91 
number of events 108.0 108.0 108.0 
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Figure 40.  Regression plot comparing the mean percent viable sperm for the 
flow cytometer and total sperm motility with the CASMA at Time 48 (N=108).  
Dashed line represents the line of equality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R=0.787 
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Figure 41.  Bland and Altman plot comparing the difference in sperm membrane 
viability with the NucleoCounter® SP-100TM and total sperm motility with the 
CASMA to the mean of the NucleoCounter® SP-100TM and total sperm motility 
at Time 48 (N=108).  Dashed lines represent + or – 2 standard deviations (lower 
and upper limits of agreement); solid line represents mean difference. 
 
 
 
Table 39. Equations and their associated values used in preparing the Bland 
and Altman plots for the NucleoCounter® SP-100TM (NC) and total sperm 
motility (TMOT) at Time 48. 
 
 
Value (equation) NC-TMOT 
absolute value 
(NC-TMOT) (NC+TMOT)/2 
sum 1724.0 2092.0 4341.0 
average 16.0 19.4 40.2 
standard deviation (SD) 21.1 17.9 28.9 
lower limit of agreement  
(average-(2*SD)) -26.2 -16.5 -17.6 
upper limit of agreement 
(average+(2*SD)) 58.1 55.3 98.0 
Range -19 – 74 19 – 74 1 - 89 
number of events 108.0 108.0 108.0 
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Figure 42.  Regression plot comparing the mean percent viable sperm for the 
NucleoCounter® SP-100TM and total sperm motility with the CASMA at Time 48 
(N=108). Dashed line represents the line of equality. 
 
 
 
 
 
 
 
R=0.766 
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Figure 43.  Bland and Altman plot comparing the difference in sperm membrane 
viability with eosin-nigrosin staining and total sperm motility with the CASMA to 
the mean of eosin-nigrosin staining and total sperm motility at Time 48 (N=108).  
Dashed lines represent + or – 2 standard deviations (lower and upper limits of 
agreement); solid line represents mean difference. 
 
 
 
Table 40. Equations and their associated values used in preparing the Bland 
and Altman plots for eosin-nigrosin staining (EN) and total sperm motility 
(TMOT) at Time 48. 
 
 
Value (equation) EN-TMOT 
absolute value 
(EN-TMOT) (EN+TMOT)/2 
sum 3110.0 3242.7 5034.0 
average 28.8 30.0 46.6 
standard deviation (SD) 24.2 22.6 25.6 
lower limit of agreement  
(average-(2*SD)) -19.6 -15.3 -4.6 
upper limit of agreement 
(average+(2*SD)) 77.2 75.3 97.8 
Range -20 – 82 20 – 82 8 - 91 
number of events 108.0 108.0 108.0 
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Figure 44.  Regression plot comparing the mean percent viable sperm with 
eosin-nigrosin staining and total sperm motility with the CASMA at Time 48 
(N=108).  Dashed line represents the line of equality. 
 
 
 
3.6.2.  Discussion: Experiment 6:  Comparison of methods for detecting sperm 
membrane viability and seminal plasma effects on sperm motion characteristics 
and membrane viability  
In agreement with other studies [5, 6, 8, 27, 28], the results of Experiment 
6 indicated that a seminal plasma concentration above 20% caused detrimental 
effects to total and progressive motility.  A decrease in sperm membrane viability 
as measured using the three methods (flow cytometry, NucleoCounter® SP-
R=0.643 
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100™, and eosin-nigrosin staining) was also observed in Experiment 6 as 
seminal plasma volume increased, which to our knowledge is reported here for 
the first time. The decrease in proportion of viable sperm was not significant 
(P>0.05) in treatments containing 50% or less seminal plasma, however these 
sperm did have a significant decrease in both total and progressive motility, 
indicating that the sperm still had intact membranes but had been rendered 
immotile.  This observation is an indication of sub-optimal processing of the 
ejaculate.   
The finding of depressed motility in sperm without apparent loss of 
viability is in contrast to the previous reports of a strong correlation between total 
and progressive motility as compared to viability [2, 13].  These contrasting 
findings may be due to the method used to produce populations of non-viable 
sperm.  In the studies conducted by Love et al., and Brinsko et al. in 2003, 
populations of non-viable sperm were produced by the addition of various 
proportions of killed sperm to the semen [2, 13].  The current research project is 
the first study, that we are aware of, using a physiological trigger, seminal 
plasma, to induce varying populations of viable and non-viable sperm.  As 
evident by the findings of this study, that as seminal plasma levels were 
increased, the correlation between membrane viability and motion 
characteristics decreased, appears to reflect the sperm being rendered immotile 
but remaining viable.  Sperm subjected to Treatment 80SP/20 (20% neat 
semen, 60% of the stallion’s own frozen/thawed seminal plasma, and 20% 
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INRA-T; thus 80% seminal plasma, but with 25% the sperm concentration of 
Treatment 80SP) had significantly lower (P<0.05) populations of viable sperm 
and total motile sperm compared to other treatments at Time 24.  This treatment 
(80SP/20) was used to determine if the viability and/or the total motility 
decreased in Treatment 80SP due to seminal plasma effects or to the increased 
sperm concentration in this treatement as compared to 50SP or 20SP, as 
storage of semen with increased sperm concentrations.  The results of this study 
indicated that while increased seminal plasma was detrimental to motility and 
membrane viability; this affect was not mitigated by lowering sperm 
concentration and in fact the lower concentration of sperm resulted in poorer 
survival.  The stallions used in this study were considered to have excellent 
semen quality and fertility and it should be noted that the effects of seminal 
plasma levels vary among stallions, ejaculates and processing techniques [7-
12].   
 While many studies have compared two or more methods for determining 
the viability of sperm in several species including equine [2, 3, 14], fowl [1, 15], 
dogs [4], and cats [16], this is the first known report comparing the use of eosin-
nigrosin staining to that of the flow cytometer using SYBR-14 and PI, as well as 
comparison of the NucleoCounter® SP-100TM to the flow cytometer and eosin-
nigrosin staining.  The flow cytometer has been considered the “gold standard” 
in terms of determining the integrity of sperm plasma membranes (viability); 
however, it is not of practical use for most laboratories and breeding facilities.  
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The Bland and Altman plots were generated to determine the amount of 
disagreement between the methods for comparing sperm viability in an attempt 
to determine if a new method (NucleoCounter® SP-100TM ) could replace an old 
method (flow cytometer or eosin-nigrosin staining) [38, 39].  Results indicate that 
the NucleoCounter® SP-100TM  was in close agreement with the flow cytometer 
at all time periods (≤ 8 percentage-point difference).  At higher percentages of 
viable sperm the agreement between the two methods was closer (≤ 6.5 
percentage point difference).  These results validate the NucleoCounter® SP-
100TM as an accurate and repeatable test for sperm membrane viability up to a 
24-hour cooling period.  Although the flow cytometer is considered to be the 
most accurate method for determination of sperm viability, from a clinical 
perspective, the results of this study show that the NucleoCounter® SP-100TM 
can be utilized as a good substitute for measurement of sperm membrane 
viability, adding another important component to the evaluation of semen from 
breeding stallions.  Eosin-nigrosin staining disagreed with the flow cytometer at 
a lesser degree (≤ 8.5 percentage points) than in comparison to the 
NucleoCounter® SP-100TM (≤ 13 percentage points).  This is in agreement with 
another study which found a 12.5% difference between the NucleoCounter® SP-
100TM and eosin-nigrosin staining [14].  A contributing factor to this finding is that 
the flow cytometer consistently overestimated the population of viable sperm in 
terms of the results obtained from the NucleoCounter® SP-100TM, whereas 
results obtained from eosin-nigrosin staining had values that estimated above 
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and below the mean difference for both the NucleoCounter® SP-100TMand the 
flow cytometer.  With a decrease in viable sperm and an increase in storage (24 
and 48 hours), the agreement of the three methods with total motility decreased 
dramatically from a 10 percentage-point difference at Time 0 to a 20-30 
percentage-point difference after 24 and 48 hours of storage, respectively.  
These findings support the previous statement that as semen is stored at sub-
optimal seminal plasma volumes (≥ 50%), the relationship between motion 
characteristics and viability weakens. 
3.7.  Experiments 7-9  
 A single gel-free ejaculate was collected using the procedure previously 
described.  All initial raw semen parameters were obtained and recorded.  The 
semen was aliquoted out into three treatments.  Each treatment addressed one 
of the following:  1) Effect of buffer type (PBS, Garner’s solution with and without 
SYBR-14 or INRA-T) on sperm membrane viability determination (Experiment 
7); 2) Effect of incubation time after addition of SYBR-14 and propidium iodide 
on sperm viability measured by flow cytometry (Experiment 8); 3) Ability of the 
flow cytometer and NucleoCounter® SP-100TM to measure absolute zero 
viability (Experiment 9). For Experiments 7 and 8, semen was extended in INRA-
T to a total volume of 30 mL containing 80% seminal plasma (24 mL neat semen 
and 6 mL extender) and was placed in two 15 mL conical tubes to be used for 
NucleoCounter® SP-100™ and flow cytometer analysis.  In Experiment 9, a 5 
mL aliquot of raw semen was dispensed into a cryovial and stored away from 
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direct light at room temperature (23°C) until all other experiments were 
complete.  Three replicates were performed on each treatment in each 
experiment.  The protocols for the NucleoCounter® SP-100TM and flow 
cytometer were followed according to the methods described previously unless 
stated otherwise in the experiments.   
  3.8.   Experiment 7: Effect of diluent type (PBS with and without SYBR-14, 
Garner’s solution or INRA-T)  
   The semen was diluted in a cryovial according to a manufacturer 
recommended dilution factor previously described in materials and methods in 
one of four diluents.  The diluent treatments used included 1) PBS; 2) INRA-T; 3) 
Garner’s solution; 4) and PBS with 0.4 µL SYBR-14 (0.04 µM).  The samples 
were run in a staggered order dependent on treatment to rule out any 
incubation-time effect on viability. 
 3.8.1.  Results: Experiment 7: Effect of diluent type (PBS with and without 
SYBR-14, Garner’s solution or INRA-T)  
 The NucleoCounter® SP-100TM showed an error window and was unable 
to read non-viable concentrations when INRA-T was used as a diluent 
(Treatment 2) instead of PBS.  There were no differences among the mean 
percent viable sperm for the other three treatments (Table 42). 
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Table 41.  Effect of diluent type on mean percent viable (mean ± SD) sperm for 
treatments 1, 3, and 4 using the NucleoCounter. 
 
Treatment Mean (% viable)± SD 
1 91.7±1.2 
3 90.7±0.6 
4 90.0±0 
   
 
3.8.2.  Discussion: Experiment 7: Effect of diluent type (PBS with and without 
SYBR-14, Garner’s solution or INRA-T) 
 The opaque quality of INRA 96 is possibly the cause of the error 
associated with Treatment 2.  Although the NucleoCounter® SP-100TM is 
capable of reading semen diluted in extender, the recommended use of PBS as 
a diluent is used to dilute out the sample allowing the NucleoCounter® SP-100TM 
to obtain a non-viable concentration.  There were no differences among the 
remaining treatment groups (Treatment 1, 3, 4) indicating that PBS with and 
without SYBR-14, and Garner’s solution did not cause detriment to sperm 
viability or changes in the ability of the NucleoCounter® SP-100TM to detect 
viability.   
3.9. Experiment 8:  Effect of incubation time after addition of SYBR-14 and 
propidium iodide on sperm membrane viability measured by flow cytometry 
 A 2.5 mL aliquot of extended semen was placed in each of four flow 
cytometer tubes and processed for analysis on the flow cytometer using one of 
the following treatments: 1) immediate analysis of viability after addition of the 
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SYBR-14 /PI to the semen sample; 2) similar to Treatment 1 except the sample 
was incubated for 5 minutes; 3) consisted of the addition of SYBR-14 to the 
semen sample, a 5 minute incubation period, then addition of PI to the semen 
sample followed by another 5 minute incubation period prior to analysis; 4) 
utilized the original protocol previously described in materials and methods (10 
minute incubation time after SYBR-14 addition, then 5 minute incubation after PI 
addition).  
3.9.1. Results: Experiment 8: Effect of incubation time after addition of SYBR-14 
and propidium iodide on sperm membrane viability measured by flow cytometry 
 There was no effect of incubation time on assessment of sperm viability 
among treatments (Table 42). 
 
Table 42.  Effect of incubation time after addition of SYBR-14 and prodidium 
iodide on sperm viability measured by flow cytometry. 
 
Treatment Mean ± SD 
1 93.9 ± 2 
2 92.8 ± 0.5 
3 92.7 ± 0.3 
4 93.3 ± 0.2 
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3.9.2. Discussion: Experiment 8: Effect of incubation time after addition of 
SYBR-14 and propidium iodide on sperm membrane viability measured by flow 
cytometry 
 This experiment was conducted to determine if sperm viability, or 
determination of sperm viability, changed with a longer incubation time.  As 
evident by the results for sperm viability in Table 42, there were no differences 
for sperm viability when immediate analysis (Treatment 1) was compared to a 
15-minute incubation time (Treatment 4), therefore length of incubation does not 
affect determination of sperm viability via flow cytometry. 
4.0. Experiment 9:  Ability of the flow cytometer and NucleoCounter® SP-100TM 
to measure absolute zero sperm membrane viability  
Data collected from Experiment 6 showed, at times, that when the 
NucleoCounter® SP-100TM gave a viable reading of 0%, the flow cytometer was 
still reading a small population of viable cells.  It is therefore not clear which 
method was correct. To answer this question, a 5 mL aliquot of raw semen 
stored in a cryovial was plunged in liquid nitrogen until frozen then thawed in a 
water bath set at 37°C for 5 minutes.  This was repeated two more times to 
damage sperm membranes resulting in a sperm sample with assumed zero 
viability.  The semen was analyzed on the flow cytometer using the protocol 
previously used in Experiments 4-6 and with the NucleoCounter® SP-100TM 
(PBS as diluent) as previously described in materials and methods. 
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4.0.1: Results: Experiment 9: Ability of the flow cytometer and NucleoCounter® 
SP-100TM to measure absolute zero sperm membrane viability 
 When sperm viability was assessed using the flow cytometer on the raw 
semen sample subjected to freezing in liquid nitrogen, the average percent 
viable population was 0.5% with a standard deviation of 0.12.  When this same 
sample was assessed using the NucleoCounter® SP-100TM, the average 
percent viable population was 3% with a standard deviation of 3.6.  
4.0.2: Discussion: Experiment 9: Ability of the flow cytometer and 
NucleoCounter® SP-100TM to measure absolute zero sperm membrane viability 
 From these results, it appears that the flow cytometer was able to 
measure absolute zero viability indicating that results from Experiment 6 were 
probably correct in that the flow cytometer measured the viability more 
accurately than did the NucleoCounter® SP-100TM.  In this experiment, the 
NucleoCounter® SP-100TM ,results indicated a population of viable cells and the 
how standard deviation was larger than that of the flow cytometer (3.6 versus 
0.12) which is another indication of the accuracy of the flow cytometer when 
compared to the NucleoCounter® SP-100TM.  It should also be noted that one of 
the three replicates using the NucleoCounter® SP-100TM did give a reading of 
<0% non-viable.   
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4. SUMMARY 
 This was the first study to assess the relationship between sperm motion 
characteristics (total and progressive motility) and sperm viability utilizing varying 
amounts of seminal plasma to induce mimic varying populations of viable sperm, 
and three different methods (flow cytometer, NucleoCounter® SP-100TM, and 
eosin-nigrosin) for detecting sperm viability.  The findings of this study 
suggested that the proportion of motile sperm decreased the relationship 
between motion characteristics and sperm viability in that the motion 
characteristics decreased at a faster rate than did the sperm viability.  
The Nucleocounter SP-100 appears to be an acceptable method for 
evaluating sperm viability.  The advantages of using the NucleoCounter® SP-
100TM as a means for detecting sperm viability are: 1) the cost and expertise 
associated with purchasing and using the instrument are far less than those 
needed for purchasing, running and maintaining the flow cytometer; 2) based on 
statistics and Bland and Altman plots, the NucleoCounter® SP-100TM holds 
better agreement with the flow cytometer and is a more repeatable method for 
determining sperm viability when compared to eosin-nigrosin staining; and 3) the 
NucleoCounter® SP-100TM is more readily available for clinical purposes and its 
use as an instrument for sperm concentration has also been validated.  In 
contrast, eosin-nigrosin staining had poor accuracy in determining sperm 
viability at lower levels of viability, and had the highest variability among the 
methods examined. 
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5.  FUTURE AIMS 
This was the first known study to utilize a physiological method (varying 
volumes of seminal plasma and storage of semen) to induce detrimental effects 
to the plasma membranes of sperm.  When comparisons were made between 
sperm viability and motion characteristics, results suggested that in higher 
volumes of seminal plasma the sperm are rendered immotile but remained 
viable (plasma membranes intact).  Future studies should expand on this finding 
to confirm these results, and to determine if the sme findings exist when sperm 
motility is dereased due to factors other than storage.  Previous studies have 
found strong correlations between motion characteristics and viability when 
known amounts of dead sperm were added. 
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